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 ABSTRACT 
  Growth hormone (GH) deficiency is associated with impaired learning and 
memory. One possible target for GH effects on memory is the hippocampus, a 
brain region containing GH receptors (GHRs). To determine if GH acutely alters 
hippocampal function, recombinant human GH (rhGH) was applied to in vitro rat 
hippocampal brain slices. Extracellular recordings were used to assess effects of 
GH on the field EPSP (fEPSP) and long-term potentiation (LTP) of the fEPSP.  
GHR expression was measured in GH-treated and control rat hippocampal slices 
using RT-PCR. The GH signaling pathway was investigated by studying the 
effect of GH on the fEPSP after block of Janus kinase (JAK) by tyrphostin AG 
490, phosphoinositide-3-kinase (PI3-kinase) by wortmanin, and mitogen-
activated/extracellular response protein kinase kinase (MEK) by U0126. To 
determine if protein synthesis is required, hippocampal slices were perfused with 
cycloheximide, a protein synthesis inhibitor. I examined the effects of GH on 
pharmacologically isolated N-methyl-D-aspartate receptor (NMDAR)-and α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR)-mediated 
fEPSPs. Using western blotting, total and phosphorylated STAT5A/B, and 
NMDAR subunits NR1, NR2A, and NR2B were measured in GH-treated and 
control slices. 
   GH caused a gradual (2 hr) increase in fEPSP amplitude during 
application that was maintained for more than 4 hours. Prior GH treatment (3hr) 
prevented additional potentiation by tetanus (100Hz, 1s), indicating that similar 
mechanisms contribute to both. GH caused equivalent enhancement of isolated 
 ii
 NMDAR-fEPSPs and dual component fEPSP, indicating that GH effects are 
mediated in part by NMDARs. GH enhancement of fEPSPs was blocked by 
inhibitors of protein synthesis, JAK, PI3-kinase, and MEK, implicating all of these 
signaling mechanisms in GH enhancement of synaptic transmission. In vitro GH 
treatment of hippocampal brain slices for 15-30 min failed to alter either total or 
phosphorylated STAT 5a/b. In vitro GH treatment of hippocampal brain slices       
(3 hr) increased GHR mRNA, decreased NR2B protein, and increased 
NR2A/NR2B ratio. My results clearly demonstrate a previously unknown role for 
GH as a short-term modulator of hippocampal synaptic function. 
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 Neural growth hormone 
Growth hormone (GH) is a polypeptide hormone formed of 191 amino 
acids in a single chain (Corpas et al., 1993).  It is secreted mainly by the 
somatotropic cells of the anterior pituitary gland under the control of two main 
factors secreted from the hypothalamus, GH releasing hormone (GHRH) and GH 
inhibiting hormone or somatostatin (Corpas et al., 1993; Tannenbaum, 1990; 
Vance et al., 1985; Reichlin, 1983). GH secretion is pulsatile (Wajnrajch, 2005; 
Vance et al., 1985). GH secretion is increased during deep sleep ((Wajnrajch, 
2005), by exercise (Berg and Bang, 2004), during starvation (Tanaka et al., 
2004). GH secretion is decreased during aging, and by obesity (Iranmanesh et 
al., 1991).  
Figure 1.  Control of GH secretion. GH is secreted under the control of GHRH 
and GH inhibiting hormone or somatostatin. GH secretion has a feed back 
regulatory effect on the hypothalamus, inhibiting the secretion of GHRH and 
increasing the secretion of somatostatin. The main stimuli increasing GH 
secretion are deep sleep and exercise.  
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Figure 2.  Variations in human GH secretion throughout the day. 
Major pulses of GH secretion occur in response to strenuous exercise  
and deep sleep. The secretory profile for GH in rats is also pulsatile, ranging up 
to several hundred ng/ml. 
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  It has recently become well established that GH gene expression is not 
restricted to the pituitary gland but also occurs in many extra-pituitary tissues 
including both the central and peripheral nervous system (Harvey and Hull, 
2003). GH immunoreactivity is detected in the brains of human embryos at 8 
weeks of development, before its appearance in the pituitary at the end of the 
first trimester (Costa et al., 1993). On the tenth day of the 22 days gestational 
period, GH starts to appear in rat brain: two days before its appearance in the 
pituitary gland (Hojvat et al., 1982). GH is found in the midbrain, hippocampus, 
cortex, striatum, olfactory bulb and cerebellum, at higher concentration in female 
rats compared to male rats (Mustafa et al., 1994b). In the chicken high GH levels 
are detected in the spinal cord as early as the second day of embryonic 
development, before its appearance in the pituitary at mid-late incubation 
(Harvey and Hull, 2003).   
 
GH is present in hypothalamic as well as extra-hypothalamic areas of 
chicken brain (Render et al., 1995). GH immunoreactivity has been detected in 
the spinal cord, hippocampus, hypothalamus, otic and optic vesicles of chicken 
embryonic brain (Murphy and Harvey, 2001). GH immunoreactivity has been 
detected in the peripheral nervous system of chick embryos, particularly in the 
trigeminal and vagal nerves (Murphy and Harvey, 2001). GH immunoreactivity 
has also been detected in the hippocampus, periventricular, paraventricular, 
inferior and infundibular hypothalamic nuclei, in the medial and lateral septal 
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 area, and in the median eminence of turkey brain and ringdove brain (Ramesh et 
al., 2000).  
Cerebrospinal GH could reflect either GH synthesized in the CNS or 
sequestration of GH from systemic circulation (Harvey and Hull, 2003). In support 
of the first hypothesis, trace amounts of GH have been detected in serum 
following hypophysectomy (Lazarus and Scanes, 1988). Also the presence of 
higher concentration of GH in the hypothalamic hypophyseal blood compared to 
the peripheral blood indicates central secretion of GH into the systemic 
circulation (Paradisi et al., 1993).  
 
 The abundance and wide spread presence of GHRs in the brain supports 
the possibility that neural tissues are target sites for GH action (Harvey et al., 
1993). Hippocampal GHRs have been identified in both humans and rats (Lai et 
al., 1993; Zhai et al., 1994). Recently the GHR cDNA nucleotide sequence has 
been described in rat hippocampus (Thornwall et al., 2001).  
 
Cerebrospinal fluid (CSF) levels of GH are much lower compared to that 
of the systemic circulation, reflecting the poor permeability of cerebral 
microvessels (Prahalada et al., 1999). Cerebrovascular permeability is greatest 
during fetal development and decreases with age (Mustafa et al., 1995). 
Increased cerebrovascular permeability after CNS injury leads to rapid 
upregulation of GHRs in the endothelium of cerebral blood vessels (Scheepens 
et al., 1999), suggesting the possibility of receptor mediated sequestration of GH 
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 from the systemic circulation (Harvey and Hull, 2003). GHRs are also abundant 
in choroid plexus, supporting the peripheral origin of CSF GH (Harvey and Hull, 
2003). CSF GH level is increased following its peripheral administration in 
humans (Nyberg and Burman, 1996), with a dose-dependent increase in CSF 
GH concentration in patients who received s.c. injections of GH (Burman et al., 
1996). Peripheral origin of central GH is also supported by the higher CSF level 
of GH in patients suffering from acromegaly (Schaub et al., 1977). Additional 
support for the peripheral origin of central GH is seen in the correlated decline in 
CSF and plasma GH levels with age (Heinze et al., 1998). 
 
Therapeutic applications of growth hormone   
Growth hormone (GH) is considered a successful therapeutic drug for 
children and adults with GH deficiency, as well as for growth retardation due to 
chronic renal disease, Turner syndrome, and in children born small for 
gestational age (Kappelgaard et al., 2004). Short children born small for 
gestational age (SGA) have reduced serum leptin levels which are inversely 
correlated with their chronological age (Boguszewski et al., 1997). Serum leptin 
levels correlate with the growth response to GH treatment and may be used as a 
marker for predicting the growth response to GH treatment (Boguszewski et al., 
1997). Hyperlipidemia, diabetes mellitus type 2, and coronary heart disease are 
commonly associated with being born SGA (Pareren et al., 2003). GH treatment 
has a positive effect for up to 6 years on body composition, blood pressure (BP), 
and lipid metabolism (Sas et al., 2000). Therefore, GH treatment might 
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 counteract the reported higher risk of cardiovascular diseases in later life for 
children born SGA (Sas et al., 2000).  
 
It is well established that GH therapy has beneficial effects on statural 
growth in children (Darendeliler et al., 2005). High dose GH therapy starting 
before puberty accelerates bone age and induces an earlier onset of puberty 
(Kamp et al., 2002). In short children born SGA, three years of GH treatment 
normalized their height during childhood and increased bone maturation 
proportionately to the height gain (Arends et al., 2003). Thus, it is better to start 
GH treatment at an early age in order to achieve a normal height before puberty 
starts (Arends et al., 2003). Serious GH deficiency and short stature can be 
treated by KP-102 (D-alanyl-3-(2-naphthyl)-D-alanyl-L-alanyl-L-tryptophyl-D-
phenylalanyl-L-lysinamide dihydrochloride, growth hormone-releasing peptide-2, 
GHRP-2), which potently promotes growth hormone (GH) release by acting at 
both hypothalamic and pituitary sites (Furuta et al., 2004). There are dose-
dependent increases in final height in children with idiopathic short stature 
treated with GH (Wit et al., 2005).  
  
One year of GH treatment in pre-pubertal children with idiopathic GH 
deficiency (GHD), Turner syndrome (TS) or idiopathic short stature (ISS), and 
short pre-pubertal children born SGA, normalized progression of bone age (BA) 
(Darendeliler et al., 2005). GH treatment for three years induced proportionate 
growth resulting in a normalization of height and other anthropometric 
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 measurements, including head circumference, in contrast to untreated SGA 
control subjects (Arends et al., 2004). Lowered intelligence, poor academic 
performance, low social competence, and behavioral problems are also 
associated with being born SGA (Pareren et al., 2003). In adolescents born SGA, 
GH therapy produced marked improvement over time in behavior and self-
perception parallel to GH-induced catch-up growth (Pareren et al., 2004).  
 
 Prader-Willi syndrome (PWS) is a genetic disease that is caused by an 
alteration in the molecular composition of a critical region of chromosome 15 
(Whitman et al., 2002). PWS is characterized by obesity, hyperphagia, hypotonia, 
short stature, hypogonadism, and a neurobehavioral profile that includes 
cognitive deficits, learning problems, and behavioral difficulties that increase in 
both quantity and severity over time (Whitman et al., 2002). In addition to 
hyperphagia, which has proven refractory to all psychopharmocologic 
intervention, decreased energy expenditure and reduced physical activity often 
lead to morbid obesity in patients with PWS (Whitman et al., 2002). GH treatment 
produced significant reduction of depressive symptoms and improvements in 
physical parameters in children over 11 years old with PWS (Whitman et al., 
2002).  
 
Human growth hormone has become a popular ergogenic aid, improving 
exercise performance among athletes (Stacy et al., 2004). GH has 
supraphysiologic effects leading to lipolysis, with increased muscle volume 
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 (Stacy et al., 2004).  In addition, GH is considered an anti-aging drug and has 
improved athletic performance in isolated studies (reviewed in Stacy et al., 2004).   
 
Both recombinant human growth hormone (rhGH) and insulin-like growth 
factor-I (IGF-I), have been considered beneficial for diseases associated with 
increased catabolism such as acquired immune deficiency syndrome (AIDS) 
(Laurence, 1995).  It has now been confirmed that GH as well as IGF-I produce 
increases in body weight, lean body mass, and sense of well-being among HIV+ 
individuals because of their ability to promote nitrogen retention, protein 
synthesis, and lipolysis (Laurence, 1995).  GH also augments cellular immune 
function and modulates T lymphocyte trafficking in animal models of immune 
suppression, suggesting benefit for any immune suppressive disorders, including 
HIV infection (Laurence, 1995).   
 
Growth hormone and memory function 
  Recent studies have shown that GH affects many functions of the central 
nervous system, with beneficial effects on memory, alertness and motivation 
(Fargo et al., 2002). GH deficiency (GHD) has well known detrimental effects on 
cognition and memory in humans.  General fatigue, lack of concentration, 
memory disabilities and a diminished subjective sense of wellbeing are all 
problems detected in untreated adult GHD patients (Bjork et al., 1989; McGauley 
et al., 1990). Sleep disturbances and psychologically immaturity are problems of 
young GHD patients (Hayashi et al., 1992). Animal studies support these human 
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 observations.  In a passive avoidance task in young rats (3 months old), GH 
administration facilitated long-term memory and delayed extinction (Schneider-
Rivas et al., 1995).  In this study, old rats (24 months old) did not benefit from GH 
treatment. However, in other studies using a different learning task, the Morris 
water maze, learning in old rats was improved by treatment with GHRH 
(Thornton et al., 2000) or GH itself (Ramsey et al., 2004).   
 
Long Term Potentiation (LTP) is a Model System for Mechanisms of 
Memory  
 Physiologically, memories are caused by changes in the strength of 
synaptic transmission between neurons resulting in the formation of new 
pathways or facilitated pathways for transmission of nerve signals following 
previous neural activity (Guyton and Hall, 2000). Long term potentiation (LTP) is 
a long-lasting increase in the strength of synaptic transmission between nerve 
cells, induced in response to high frequency afferent stimulation (Bliss and Lomo, 
1973).  LTP has been most extensively studied in the hippocampus, a brain 
region known to be involved in memory functions (Bliss and Collingridge, 1993). 
LTP is considered the best available model for studying the synaptic 
modifications that underlie memory formation and storage (Bliss and 
Collingridge, 1993), and for this reason interest in LTP has steadily increased.  
 
A novel form of synaptic plasticity, homosynaptic long-term depression 
(LTD), has also recently been documented. LTD, like LTP, requires Ca2+ entry 
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 through NMDARs (Bear and Malenka, 1994). Recent studies suggest that LTD 
and LTP are functionally inverse processes, and that the mechanisms of LTP 
and LTD may converge at the level of specific phosphoproteins (Bear and 
Malenka, 1994). Although the induction of both LTD and LTP require Ca2+ influx, 
a stronger depolarization and a greater increase in [Ca2+]i are required to induce 
LTP than to initiate LTD (Artola and Singer, 1993). 
 
Glutamate receptors (GluRs) 
Glutamate is the major excitatory neurotransmitter in the central nervous 
system, and GluRs are widely expressed throughout all major division of the 
central nervous system (McBain and Mayer, 1994). Ionotropic GluRs are 
classified into three major classes: alpha-amino-3-hydroxy-5-methyl-4-isoxazole 
proprionate (AMPA), kainate and N-methyl-D-aspartate (NMDA), based on their 
electrophysiological and pharmacological properties (McBain and Mayer, 1994). 
Although the first recognized glutamate receptors were ligand-gated ion 
channels, a large number of G protein-coupled GluRs are also expressed 
throughout the CNS (Nakanishi, 1992).  
 
N-methyl-D-aspartate receptors (NMDARs) are selectively activated by 
NMDA, a synthetic analogue of aspartic acid, which does not occur naturally in 
the brain (Watkins and Evans, 1981). The NMDAR response to NMDA is potently 
blocked by aminophosphovalerate (AP5) (McBain and Mayer, 1994).  Responses 
at NMDARs are strongly voltage-dependent and show high Ca2+ permeability 
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 (McBain and Mayer, 1994).  The AMPA/ kainate subtypes of GluRs are also 
ligand-gated ion channels for which AMPA and kainate act, respectively, as 
preferential agonists. Both AMPA and kainate responses are blocked by a 
related set of quinoxaline diones (CNQX, DNQX, NBQX), but not by AP5 
(McBain and Mayer, 1994).  Non NMDARs (AMPA and kainate receptors) in 
general have only weak voltage dependence and low Ca2+ permeability (McBain 
and Mayer, 1994).    
 
Four genes (GluR A-D/GluR1-4) code for the AMPA glutamate receptor 
subunits (Schoepfer et al., 1994). NMDARs are formed by coexpression of the 
NR1 and one or more members of the NR2 family (NR2A-D) of genes (Schoepfer 
et al., 1994). The NR1 subunit is expressed throughout the brain and serves as a 
general partner for association with NR2 subunits (Monyer et al., 1992). The 
kinetic and pharmacological properties of NMDARs are dependent on the 
specific NR2 subunit expressed (Schoepfer et al., 1994).   
 
GluRs, LTP, and memory   
GH affects expression of NMDARs, which are required for normal memory 
function (Le Greves et al., 2002). Insertion of new GluRs into the postsynaptic 
membrane (Nayak et al., 1998; Shi et al., 1999) and the phosphorylation of the 
existing GluRs (Soderling and Derkach, 2000) are putative mechanisms 
underlying memory formation.  NMDARs have an important role in synaptic 
plasticity, synaptogenesis, and excitotoxicity (Mallon et al., 2004). In cultured 
 1212
 neurons, insertion of GluR1-containing AMPARs into neuron membranes was 
induced by NMDAR activation, highlighting the role of NMDARs in synaptic 
plasticity (Passafaro et al., 2001).  
 
 These findings demonstrate a mechanistic long-term relationship between 
GH, memory function, NMDARs and LTP. Although the beneficial therapeutic 
effects of GH on memory and cognition  are well known, the underlying synaptic 
mechanisms and their relation to GluRs in general and NMDARs in particular, as 
well as the GH signaling pathway, have not been well investigated in the 
hippocampus, or for that matter, any other brain region. The purpose of my 
dissertation is to investigate possible short term effects of GH on synaptic 
transmission in the CA1 area of rat hippocampus, and the mechanisms 
underlying those effects. In assessing the potential role of GH as a short-term 
regulator of hippocampal function, I addressed three related questions. 
First, does GH alter synaptic function in hippocampal area CA1, and if so, how?  
To answer this question I applied GH to rat hippocampal brain slices and 
examined excitatory synaptic transmission for any GH-induced changes.  A 
paired-pulse stimulation protocol was used to determine whether any change in 
synaptic strength was accompanied by an alteration in the presynaptic release of 
glutamate.  I also examined the effect of brief tetanization (100 Hz, 1 s) following 
3 hr of GH pretreatment, to determine if both GH and brief tetanus act through 
common mechamisms to regulate hippocampal synaptic transmission.  The first 
section of my dissertation includes these experiments. 
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 Second, what signaling pathway(s) are responsible for short-term effects of GH 
on hippocampal synaptic function, and is synthesis of new proteins required for 
these effects?  I hypothesized that GHR signaling in hippocampus would use 
signaling pathways previously described in other tissues.  This hypothesis was 
tested by examining the effects of pharmacological inhibition of specific 
components of the hypothesized hippocampal GHR signaling pathway.  These 
experiments form the basis of the second section of my dissertation. 
Third, I asked whether GH effects on hippocampal synaptic function are 
mediated by NMDARs or AMPARs. I also asked if short-term treatment with GH 
has similar consequences on NMDAR expression as long-term, chronic 
treatment with GH.  To answer the first of these questions, I used specific 
neurotransmitter receptor antagonists to pharmacologically isolate NMDAR and 
AMPAR components of synaptic transmission, tested GH for effect on these 
isolated, components and compared the isolated NMDAR-mediated fEPSPs 
(fEPSPNs) and isolated AMPAR-mediated fEPSPs (fEPSPAs) to the dual 
component fEPSPs.  To answer the second question I used western blotting to 
measure NMDA-NR1, NR2A, and NR2B expression levels in GH treated and 
control rat hippocampal slices. The third section of my dissertation contains the 
results of these experiments. 
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Section I 
GH Enhances Excitatory Synaptic Transmission in Area CA1 of 
Rat Hippocampus 
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 Introduction 
 
Growth hormone and cognitive function  
       Age-related reductions in growth hormone secretion and cognitive 
impairments associated with aging are well documented. Carlson et al. (1972) 
reported a loss of nocturnal surges of GH in elderly individuals. 
 
In adult hypopituitary patients with GH deficiency, rhGH treatment for 3 
months had a beneficial effect on attentional performance (Oertel et al., 2004). 
The P300 event-related potential (ERP) is a positive deflection in the EEG which 
occurs with a 300 ms latency following a novel or surprising event. The P300 
ERP is thought to reflect cognitive and memory processing in frontal and 
temporal lobes, and it is altered in neurological patients with various cognitive 
impairments (Golgeli et al., 2004). P300 ERP latencies were prolonged in GHD 
patients with Sheehan's syndrome, indicating cognitive impairment.  Six months 
of GH replacement therapy (GHRT) significantly elevated serum IGF-I levels, and 
improved P300 latencies, indicating normalization of cognitive function by GHRT 
(Golgeli et al., 2004).  
 
Aging is associated with both declining activity of the growth hormone-
insulin-like growth factor-I (GH-IGF-I) axis and with a decrease in cognitive 
function (Arwert et al., 2003).  An oral mixture of glycine, glutamine and niacin 
can enhance GH secretion and improve mood and cognition in healthy middle-
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 aged and elderly subjects (Arwert et al., 2003). In a two year study, Stouthart et 
al (2003) examined psychological and cognitive consequences of discontinuation 
and restoration of GH treatment in young adults with childhood-onset growth 
hormone deficiency. Discontinuation of GH treatment led to a decrease in quality 
of life (QoL) within 6 months, and this effect was counteracted within 6 months 
after restarting GH treatment (Stouthart et al., 2003).  A significant decrease in 
IGF-I level and an increase in the number of psychological complaints and 
depression were observed in the first 6 months of the GH discontinuation period 
(Stouthart et al., 2003). Increased IGF-I level, decreased anxiety and improved 
QoL were observed in the first 6 months of GH restoration (Stouthart et al., 
2003). Depression scores tended to decrease across the 12 month treatment 
period.  The intra-subject IGF-I level was negatively correlated with depression, 
fatigue, tension and anxiety, and was positively correlated with vigor and memory 
during the 2-year discontinuation and treatment period (Stouthart et al., 2003).   
 
Both GH and IGF-1 affect the hippocampus. Hippocampal IGF-1 mRNA 
levels were increased by 1 week of treatment with either GH or GH-releasing 
peptide-6 (Fargo et al., 2002). The same effect was seen in the hypothalamus 
and cerebellum, but not the cerebral cortex (Fargo et al., 2002). Trace 
conditioning, a variant of Pavlovian conditioning, requires a learned association 
between two stimuli that are discontiguous in time, and the correct differentiation 
between the interstimulus interval, which is stable, and the intertrial interval, 
which is variable.  Hippocampal GH mRNA, assessed by microarray, real-time 
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 PCR and in situ hybridization, was dramatically up-regulated following 200 trials 
of trace conditioning (Donahue et al., 2002). In addition, somatostatin mRNA 
which encodes a direct antagonist of GH secretion was reduced during trace 
conditioning (Donahue et al., 2002). 
 
 Lemon et al. (2003) examined learning on an 8 arm radial maze in 
transgenic mice which over-expressed growth hormone (TGM). TGM had 
elevated and progressively increasing free radicals (reactive oxygen and nitrogen 
species) in brain that strongly correlated with reduced survivorship. Compared to 
controls, TGM mice showed enhanced learning during early adulthood, but 
accelerated decline of learning during aging.  The cognitive decline of TGM was 
abolished by a complex "anti-aging" dietary supplement formulated to promote 
membrane and mitochondrial integrity, increase insulin sensitivity, reduce free 
radicals, and ameliorate inflammation.  
 
Long Term Potentiation (LTP) is a Model System for Mechanisms of 
Memory  
 Long term potentiation (LTP), a long lasting enhancement of synaptic 
transmission in response to high frequency stimulation (HFS) (Bliss and Lomo, 
1973), represents a good model for studying the synaptic modifications that 
underlie memory formation and storage (Bliss and Collingridge, 1993). In the 
CA1 area of the hippocampus, LTP is triggered by calcium influx into 
postsynaptic neurons. NMDARs are a major route for this calcium entry (Bliss 
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 and Collingridge, 1993). Under some circumstances, metabotropic GluRs and 
voltage-gated calcium channels also contribute to postsynaptic calcium increase.  
The postsynaptic Ca2+ signal triggering LTP is transient; sustained enhancement 
of synaptic transmission depends on Ca2+-activated, postsynaptic signaling 
pathways. These pathways lead to the insertion of new GluRs into the 
postsynaptic membrane (Nayak et al., 1998; Shi et al., 1999) and the 
phosphorylation of existing GluRs (Soderling and Derkach, 2000). Enhanced 
glutamate release from the presynaptic terminals also contributes to the 
maintenance of LTP (Bekkers and Stevens. 1990; Schulz et al., 1994; Kullman et 
al., 1996). These mechanisms support LTP during the first few hours Longer 
lasting synaptic enhancement requires gene expression and synthesis of new 
proteins (Stanton and Sarvey, 1984; Huang and Kandel, 1994; Nguyen et al., 
1994; Frey et al., 1996), and is accompanied by structural alterations of the 
synapse (Desmond and Levy, 1988; Trommald et al., 1996; Toni et al., 1999). 
 
 The use of LTP as a model for studying memory is supported by the 
importance of hippocampus in memory (Squire and Zola-Morgan, 1992). In 
addition, behavioral experiments in animals have shown that pharmacological 
and genetic manipulations which prevent normal NMDAR function cause parallel 
disruption of LTP and memory (Morris et al., 1986; Davis et al., 1992; Tsien et 
al., 1996). Although most experiments have been conducted on rats, mice and 
nonhuman primates, normal human memory performance is also dependent on 
hippocampal NMDARs (Grunwald et al., 1999). In addition to NMDARs, other 
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 components of the signaling pathways responsible for LTP have been implicated 
in learning and memory, including metabotropic GluRs (Riedel et al., 1994; Kaba 
et al., 1994) and protein kinases (Mathis et al., 1992; Silva et al 1992). These 
findings demonstrate that a common set of cellular mechanisms underlies both 
LTP and memory. 
 
The purpose of this study was to determine if short-term treatment with 
GH would alter synaptic transmission in the CA1 area of rat hippocampus. To 
achieve this goal, I examined the effects of GH application on excitatory synaptic 
transmission and on paired-pulse facilitation of excitatory synaptic transmission 
(a presynaptic, very short-duration form of plasticity).  In addition I examined the 
effect of brief high frequency stimulation (HFS, 100 Hz, 1 s) following 3 hr of GH 
pretreatment, to determine if both LTP and GH act through common regulatory 
mechanisms. Electrophysiological recordings from area CA1 of rat hippocampal 
brain slices were used in these experiments. 
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 Materials and Methods 
 
Slice preparation 
 Hippocampal slices were prepared from 1.5 to 3 month old male Sprague-
Dawley rats (Hilltop Laboratory Animals).  Animals were sedated by inhalation of 
a CO2/air mixture and decapitated.  The skull was opened and the brain was 
removed and submerged in chilled, oxygenated (95% O2/5% CO2), low Ca2+/high 
Mg2+ artificial cerebrospinal fluid (ACSF), pH 7.35 and composed of:  124 mM 
NaCl, 26 mM NaHCO3, 1.2 mM NaH2Po4, 3 mM KCl, 0.5 mM CaCl2, 5 mM 
MgSO4 and 10 mM glucose.   
 
While submerged in chilled low Ca2+/high Mg2+ ACSF the brain was 
trimmed to a block containing both hippocampi.  The block was glued to the 
stage of a vibrating microtome (Campden Instruments), immersed in a bath of 
chilled, oxygenated, low Ca2+/high Mg2+ ACSF, and 400 µm coronal sections 
were cut.  Sections containing the hippocampus in transverse profile were 
selected and transferred to a small petri dish, where they were further dissected 
to free the hippocampus from surrounding tissue (Figure 3). After dissection, 
hippocampal slices were transferred to a holding chamber, where they were 
stored for later use (Figure 4). 
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Figure 3.  Preparation of rat hippocampal slices. Rat brains were blocked and 
glued to the stage of a microtome (top, left to right).  Sections were cut, collected 
and dissected to isolate individual hippocamal slices (bottom, left to right).  
 
 Slices were maintained in a holding chamber at room temperature (20-22 
ºC) at the ACSF/atmosphere (95% O2/5% CO2) interface.  The holding chamber 
was filled with standard ACSF, pH 7.35 and composed of 124mM NaCl, 26mM 
NaHCO3, 3.4 mM KCl, 1.2 mM NaH2PO4, 2.0 mM CaCl2, 2.0 mM MgSO4, and 10 
mM glucose.  Slices were incubated in the holding chamber for a minimum of 
one hr prior to use.  
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 interface holding chamber used for preincubation of 
dividual hippocampal brain slices. The chamber was composed of a small 
ith a 
g 
Figure 4.  The
in
glass beaker with nylon netting stretched over the opening and covered w
piece of lancet paper. The small beaker was placed inside larger beaker and 
both beakers were filled with ACSF up to a level matching the height of the 
smaller beaker. A line supplying a gas mixture (95% O2/ 5% CO2) was placed 
inside the holding chamber. The chamber was covered and kept at room 
tempreture. Hippocampal slices were incubated for at least an hour before bein
transferred to the recording chamber. 
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 Slices were withdrawn from the holding chamber as needed and placed in 
a low v
 
ield potential recording
olume (approximately 200 µl) interface recording chamber, where they 
were continuously perfused at a rate of 1-1.5 ml/min with standard ACSF.  The
recording chamber was kept at a temperature of 25±0.5 °C.  A minimum 30 min 
period was allowed for recovery after transferring slices from the holding to the 
recording chamber. 
 
F  
tials were recorded through low impedance (3-4 MΩ) 
a 
ynaptic stimulation
 Extracellular poten
glass micropipettes filled with ACSF and placed into the stratum radiatum of are
CA1 (Figure 5 and 6).  Signals were amplified (gain 1000) and filtered (0.1 - 
3,000 Hz) using a WPI DAM50 amplifier, then digitized (10 kHz; National 
Instruments) and stored on a personal computer. 
 
S  
otentials were evoked by delivery of constant voltage 
 
, 
 
 Postsynaptic p
stimuli through a bipolar stimulating electrode placed into stratum radiatum. 
Stimuli were delivered at a 15 sec interval.  In some field potential recordings
paired stimuli (50 ms interstimulus interval) were delivered in order to measure
paired-pulse facilitation.  Paired-pulse facilitation was quantified as the ratio of 
the second response divided by first response. 
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 Postsynaptic potentials evoked in standard ACSF were quantified by 
measuring the slope of the linear portion of the initial response.  Changes in 
synaptic response caused by GH treatment or LTP induction were expressed as 
percentage of baseline prior to treatment or tetanization. 
 
 
Figure 5.  The recording chamber (left) and typical placement of recording 
and stimulating electrodes (right). The recording chamber used in the study 
was Stoelting company model 51430 tissue chamber (left). A bipolar metal 
stimulating electrode and a glass recording electrode were placed into 
hippocampal area CA1. 
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Figure 6.  Schematic illustration of hippocampal synaptic organization. 
Transverse section of rat hippocampus showing the three major afferent 
pathways that form the trisynaptic circuit in hippocampus and the typical 
placement of recording and stimulating electrodes in stratum radiatum of area 
CA1. The arrows indicate the direction of information flow through the trisynaptic 
circuit. 
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 LTP induction 
 LTP was examined in standard ACSF.  LTP was induced by a single high 
frequency stimulus train (100 Hz, 1 s).  The stimulus intensity used for tetanic 
stimulation was set at the population spike threshold.  LTP was assessed in 
slices pretreated with GH (22 ng/ml, dissolved in standard ACSF) for 3 hr and in 
control slices exposed to standard ACSF only for an equivalent time period.  
Slices were pretreated in the interface holding chamber, then transferred to the 
recording chamber where they were perfused with standard ACSF for recording 
and assessment of LTP.   
 
Reagents 
 I used rhGH (Bachem). The doses used in these recordings ranged from 
0.5 to 1 nM or (11-22 ng/ml) which is within the physiological range; GH serum 
level ranged between few ng/ml and several hundred ng/ml in rats (Kimura and 
Tsai 1984; Everson and Crowley, 2004). Human GH is a potent, relatively 
selective agonist of GHRs in male rats. Mustafa et al. (1994a) reported the 
presence of specific binding sites for hGH in rat brain which were moderately 
high in hippocampus, hypothalamus and striatum. Moreover, those binding sites 
for hGH were almost exclusively somatogenic in male rat brains (Mustafa et al., 
1994b). However in female rat brain these sites display somatogenic and 
lactogenic characteristics (Mustafa et al., 1994b). This is also supported by the 
finding of Ranke et al. (1973) who studied the sex differences in binding of hGH 
to isolated rat hepatocytes. They reported that hGH binds only to somatogenic 
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 receptor in hepatocytes of male rats. However in female rats and estrogen 
treated males hGH has both somatogenic and lactogenic properties (Ranke et 
al., 1973). In summary, in male rats (used in this study) hGH has less potential to 
bind non specifically to lactogenic receptors. 
 
Data analysis 
 Field potentials were collected and analyzed using The WinWCP program 
(John Dempster, University of Strathclyde). Additional analysis was completed 
using Excel (Microsoft) and Origin (OriginLab). All statistics are presented as 
mean ± one standard error of the mean. Statistical significance was assessed 
using paired and unpaired t-test, as appropriate, with p<0.05 considered 
significant. 
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 Results 
 
Growth hormone enhanced excitatory synaptic transmission 
 I used field potential recordings (fEPSP) to determine if GH application 
affects excitatory synaptic transmission.  Application of GH (11-22 ng/ml) caused 
a slow increase in fEPSP slope (Figure 7).  Although fEPSPs began to increase 
within minutes of starting GH application, the maximal increase required 60-120 
min.  GH enhancement of fEPSP persisted for more than 4 hours  Control slices, 
exposed to ACSF for the same duration, did not show any increase in fEPSP 
slope (p<0.01, control vs GH after 60 min of application). 
 
Growth hormone did not affect paired pulse facilitation  
The GH-induced increase in fEPSP slope could be due to enhanced 
postsynaptic response to glutamate, or increased presynaptic release of 
glutamate.  Increased probability of transmitter release is accompanied by 
decreased paired-pulse facilitation (PPF) (Dobrunz and Stevens, 1997).    
Therefore, to determine if increased probability of glutamate release might 
underlie the GH enhancement, I examined PPF during GH application.  Neither 
GH treated nor control slices showed a change in PPF ratio (Figure 8).   This lack 
of change in PPF argues against an increase in glutamate release as a 
mechanism for the GH enhancement of excitatory synaptic transmission. 
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 Growth hormone inhibits LTP in area CA1 of rat hippocampus 
A single train of high frequency stimuli (HFS, 100 Hz, 1 s) failed to 
potentiate synaptic responses in slices pretreated with GH (22 ng/ml; p > 0.4). 
However, HFS with the same 100 Hz protocol caused significant enhancement of 
fEPSPs in control slices pretreated with standard ACSF (p < 0.02; Figure 9). 
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 Figure 7. 
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 Figure 7.  GH Enhanced Excitatory Synaptic Transmission in Area CA1 of 
Rat Hippocampus.  
A.  GH application (11-22 ng/ml) caused a slow enhancement of fEPSPs  
(squares) in comparison to control slices treated with ACSF only (diamonds). GH 
application began after 15 min of recording and continued for >5 hours The inset 
at top shows fEPSPs changes during the baseline and after 3 hr of GH and 
control treatment.  
B.  Summary of GH effects on fEPSPs.  fEPSPs were averaged over 15 min 
baseline period and 1 hr period during GH application. fEPSPs from GH treated 
slices were significantly enhanced compared to controls at all time points: 
*P<0.05, **P<0.01, ***P<0.005. These data represent the average of 10 slices 
treated with GH and 4 control slices. 
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Figure 8.  GH did not alter the paired-pulse facilitation (PPF) ratio.  
A.  Paired stimuli (50 ms interstimulus interval) were delivered at 15 sec intervals. 
There was no change in PPF ratio during GH application. The inset at top shows 
fEPSPs during baseline and the second hr of GH application.  Substantial paired-
pulse facilitation is seen at all times (the second response is bigger than the first 
response), but the application of GH did not alter the PPF ratio.   
B.  Summary of all recordings in which PPF was examined during GH 
application.  PPF was not significantly different during either the first or the 
second hr of GH treatment compared to the baseline (p < 0.2, n = 9) 
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Figure 9.  GH pretreatment prevented LTP in area CA1 of rat hippocampus. 
A. Stable baseline responses were recoded for a 15 min period preceding tetanic 
stimulation (100 Hz 1s). Control slices showed enhancement of fEPSPs after 
tetanus (diamonds), but LTP was completely prevented in GH pretreated slices 
(squares). The inset at top shows baseline responses and responses after 
tetanus (control upper left and GH treated upper right).  
B.  Summary of LTP results in GH pretreated and control slices. Control slices (n 
= 8) showed significant potentiation of the fEPSP (*p<0.02), but GH pretreated 
slices (n=8) failed to show any significant change in fEPSP (ns p<0.44).  
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 Discussion 
 
Short term, minutes to hours, application of GH to in vitro rat hippocampal 
brain slices enhanced excitatory synaptic transmission and also inhibited further 
potentiation by tetanus. In a recent study Fargo et al. (2002) have shown that GH 
affects many functions of the central nervous system, with beneficial effects on 
memory, alertness and motivation. Le Greves et al. (2002) observed dose 
dependent improvement in memory and learning after 1 week of daily injections 
of rhGH in hypophysectomized male rats. Memory deficiency including both short 
and long term memory is a well known syndrome in GHD patients (Deijen et al., 
1996; Aleman et al., 2000). In addition, adult patients suffering from 
hypopituitarism with GH deficiency showed improvement of attentional 
performance when treated with GH for at least 3 months (Oertel et al., 2004). An 
age-related decrease of GH is associated with defects in spatial memory in 
animals (van Dam et al., 2000), and it is well established that the decline in the 
cognitive function with aging is paralleled with decreased circulating levels of GH 
(Le Greves et al., 2002).  
 
This raises the question, how does GH treatment improve memory, 
alertness, and cognition? The process of memory storage in the brain certainly 
involves some form of synaptic modification (Rosenzwing and Barnes, 2003). 
Recent investigations have suggested a role for GH in memory, which may be 
mediated by the influence of GH on neuronal plasticity in the hippocampus. Since 
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 the hippocampus is critically important in memory and learning processes (Le 
Greves et al., 2002), I applied GH to in vitro hippocampal brain slices of rats to 
determine if it affects synaptic transmission. GH substantially enhanced synaptic 
transmission in area CA1 of rat hippocampal slices, exerting a maximum effect 
within 2 hr (Figure 7). Taken together, this suggests that GH may improve 
memory by enhancement of synaptic transmission between hippocampal 
neurons. However, prior treatment with GH for 3 hr also blocked synaptic 
enhancement induced by brief tetanus (100 Hz, 1 s), (Figure 9). How can this 
dual effect of GH be explained? 
 
Although LTP was originally described as synaptic enhancement resulting 
from high frequency electrical stimulation (Bliss and Collingridge, 1993), similar 
synaptic potentiaton may result from application of several different chemical 
compounds, including neutrophins, second messenger analogs, and 
conventional neurotransmitters. Although the term LTP typically refers to 
electrically-induced synaptic enhancement, we could say that LTP is of 2 types:  
drug-induced and electrically-induced. Drug-induced LTP has been 
demonstrated following treatment with the neurotrophins, BDNF and NT-3, 
forskolin and the membrane-permeable cAMP analog Sp-cAMPS, and also 
dopamine receptor agonists (D1 and D2) (Frey et al., 1993; Huang et al., 1994., 
Huang and Kandel, 1995; Kang and Schuman, 1995).  
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 Previous studies in hippocampal slice preparations have distinguished two 
major temporal phases of LTP, early and late, based on their sensitivities to 
inhibitors of mRNA and protein synthesis (Krug et al., 1984; Huang and Kandel, 
1994). In contrast to the early phase of LTP (E-LTP), the late phase of LTP (L-
LTP) is of greater amplitude and longer duration, lasting more than 3 hr (Kelleher 
et al., 2004a).  In contrast to the L-LTP produced by repeated tetanization, L-LTP 
produced by drugs develops gradually, requiring 1 to 2 hr to reach its maximal 
level.  Both drug- and electrically-induced L-LTP are abolished completely by 
protein synthesis inhibitors (Kelleher et al., 2004a). Previous studies indicated 
that L-LTP produced by repeated tetanization and L-LTP produced by elevation 
of intracellular cAMP share a common protein synthesis-dependent mechanism 
(Kelleher et al., 2004a). Establishment of cAMP-induced LTP prior to repeated 
tetanization blocks L-LTP (Frey et al., 1993; Huang and Kandel, 1994). The idea 
that drug-induced L-LTP can block electrically-induced L-LTP is also supported 
by the finding of Martin et al. (1997) that MAPK may be a general mechanism for 
long-term plasticity in all kinds of LTP. They found that MAPK translocates into 
the nucleus of the presynaptic but not the postsynaptic cell during 5-HT-induced 
long-term facilitation, suggesting that MAPK may play a similar role in 
hippocampal long-term potentiation. PKCζ may also play essential roles in both 
drug-induced and electrically-induced LTP, since treatment of hippocampal CA1 
pyramidal neurons with PKC ζ activators produces robust potentiation of synaptic 
transmission that occludes subsequent electrically-induced LTP (Ling et al., 
2002).  
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 I found that a brief tetanus (100 Hz, 1 s), which normally induces LTP had 
no effect in slices pretreated with GH for 3 hours This effect of GH on 
hippocampal synaptic function raises another question; does GH act through a 
similar signaling pathway to that of LTP? If so, then prior saturation of this 
pathway by pretreatment with GH should prevent subsequent electrically-induced 
LTP. In order to answer the questions raised by my first set of experiments, the 
GH signaling pathway in hippocampus must first be defined.  It will then be 
possible to compare the GH signaling pathway with the LTP signaling pathway 
which is already well described in the literature.   
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Section II 
 
Growth Hormone Signaling Pathways in Area CA1 of Rat 
Hippocampus 
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 Introduction 
 
Pretreatment with GH blocked the effect of a brief tetanus (100 Hz, 1 s) 
which normally induces LTP. This effect of GH on hippocampal synaptic function 
raises another question; does GH act through a similar signaling pathway to that 
of LTP? If so, then prior saturation of this pathway by pretreatment with GH 
should prevent subsequent electrically-induced LTP. In order to answer this 
question tetanization-induced-LTP signaling pathway(s) and GH signaling 
pathway(s) in other tisssues which are already well described in the experimental 
literature will be reviewed.  
 
Tetanization-induced L-LTP signaling pathway 
 LTP induction is disrupted by pharmacological inhibitors of the Ras 
effectors PI3-kinase (Kelly and Lynch, 2000; Lin et al., 2001; Kelleher et al., 
2004a; Sanna et al., 2002) and p44/42 MAPK (Sweatt, 2001; Adams and Sweatt, 
2002).  LTP is also inhibited in hippocampal pyramidal cells expressing a 
dominant negative form of Ras (Zhu et al., 2002). Furthermore, MEK inhibitors 
strongly reduce the induction of LTP by theta pulse stimulation (TPS) (Winder et 
al., 1999; Watabe et al., 2000). There are at least two possible roles for ERK 
activation in LTP.  First, MAPK activation has an important role in the mRNA and 
protein synthesis stages of LTP maintenance (Impey et al., 1998; Davis et al., 
2000). Second, MAPK activation contributes to LTP induction through 
downregulation of dendritic A-type K+ channels (Sweatt, 2001).  Downregulation 
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 of dendritic A-channels allows greater postsynaptic depolarization during 
tetanization, leading to greater voltage-dependent calcium influx, and enhanced 
downstream activation of calcium-dependent processes.  
 
LTP induced by short trains of TPS is almost completely blocked by the 
PI3-kinase inhibitors LY294002 and wortmannin (Opazo et al., 2003). PI3-kinase 
is important for the induction of LTP, but not for the maintenance of LTP, as PI3-
kinase inhibitors applied after LTP induction do not block LTP (Opazo et al., 
2003).  Several possible roles for PI3-kinase in LTP induction have been 
suggested. LTP-inducing patterns of synaptic stimulation activate the atypical 
PKC isoform PKCζ (Sacktor et al., 1993), and inhibitors of PKCζ inhibit LTP in 
hippocampal area CA1 (Ling et al., 2002).  PI3-kinase contributes to the early 
activation of PKCζ during LTP induction (Opazo et al., 2003), perhaps via 
activation of PDK-1 (Chou et al., 1998; Le Good et al., 1998). In addition, PI3-
kinase is important for the trafficking and insertion of some membrane proteins 
during LTP induction (Corvera and Czech, 1998; Wu et al., 1998; Rameh and 
Cantly, 1999; Lhuillier and Dryer, 2002). Finally, PI3-kinase might have a role in 
the dendritic spine changes associated with LTP and induced by either 
organizational changes of actin cytoskeleton (Rodgers and Theibert, 2002) or 
activation of synaptic NMDA receptors (Yuste and Bonhoeffer, 2001).  
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 Growth hormone signaling pathway 
Tissue sensitivity to GH.  Growth hormone (GH) differs from other 
pituitary hormones in its wide spectrum of cellular activities in several different 
tissues which are all mediated by a common receptor, suggesting tissue-specific 
differences in the post-receptor mechanisms (Hull and Harvey, 1998). One of the 
mechanisms that confers specificity is tissue sensitivity to GH stimulation. Tissue 
sensitivity depends upon the abundance of GH receptors (GHRs), the amplitude 
and pulsatility of GH secretion and the presence of non-signal transducing GH-
binding proteins (GHBPs), which result from alternate splicing of GHR gene 
transcripts (Hull and Harvey, 1998). Additional diversity stems from tissue-
specific autoregulation of GHRs and GHBPs. Hypophysectomy decreased both 
GHR and GHBP transcripts in the hypothalamus of rats by 20%; however, 
neither transcript was affected in the liver, spleen, cortex/neocortex or brainstem 
(Hull and Harvey, 1998).  On the other hand, a single bolus GH injection 
increased circulating GH concentrations, GHR and GHBP mRNA content by 25-
30 % in all brain regions and in the spleen of hypophysectomized rats (Hull and 
Harvey, 1998).  
 
GH regulation of GHRs.  GHR mRNA levels were increased within 1 hr 
of a single injection of human GH (100 µg/ rat), and maximal levels were reached 
between 3-12 hr after the injection (Vikman et al., 1991). The increase in GHR 
mRNA levels was dose dependent and also was observed after prolonged 
treatment (1 or 5 mg/kg/day for 6 days) with bovine GH. Furthermore, there was 
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 a rapid and GH-dependent regulation of GHR mRNA levels in adipose tissue 
(Vikman et al., 1991). Using PCR, GH treatment by s.c. injection for 10 days 
increased expression of GHR transcripts in the hippocampus of young adult rats, 
reflecting the ability of the hormone to reach the brain and stimulate hippocampal 
cells (Le Greves et al., 2002).  
 
Overview of GHR signaling.  The receptors for GH, prolactin, 
erythropoietin, and interleukin 2 all belong to the same large family of single 
chain transmembrane receptors (Xiaowei et al., 1995), the cytokine receptor 
superfamily. The receptors in this family have similar extracellular domains which 
are rich in cysteine, a motif that has been shown to be important in protein-
protein interaction as well as in cell-cell interaction (Bazan, 1989; Patty, 1990). 
Activation of the GHR, like other members of the cytokine receptor family, 
stimulates Janus kinase 2 (JAK2) association with the GHR, followed by tyrosine 
phosphorylation of both proteins (Argetsinger et al., 1993; Sotiropoulos et al., 
1994).  The activated GHR-JAK2 couple stimulates several signaling cascade, 
including the Ras/Raf/MEK1/MAPK pathway, the insulin receptor substrate-
1(IRS-1)/PI3kinase pathway and the STAT pathway (Liang et al., 2000).  
 
MAPK pathway. Binding of GH and prolactin (PRL) to their receptors 
activates JAK2 tyrosine kinase, the initial step in all biological actions of GH 
(Yamauchi et al., 1998). The activated GH/JAK2 complex in turn activates STATs 
as well as ERK/MAPKs (Winston and Hunter, 1995). The GHR/JAK2-mediated 
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 activation of ERK2/MAPK is through both Ras and Raf (Winston and Hunter, 
1995). GH promoted the rapid, transient association of SHC with the Grb2-SOS 
complex. This correlated with the time course of Ras, Raf, and MEK activation 
with Ras, Raf, and MEK returning to near basal activity by 15 or 30 min despite 
the continuous presence of GH (Vanderkuur et al., 1997).  
  
Phosphorylation of the JAK2-GHR complex, through activation of MAPK, 
leads to increased IGF-1 mRNA expression in liver (Xu et al., 1995). The 
GHR/JAK2-MAPK stimulation of IGF-1 production shows an age-related decline. 
In 17-month-old female C57BL/6 mice IGF-1 gene expression is decreased, but 
this is not directly associated with decreased GHR complex phosphorylation or 
MAPK activity (Xu et al., 1995). However, by the age of 31 months the decrease 
in IGF-1 gene expression is associated with a marked decline in GHR and JAK2 
phosphorylation and decreased MAPK activity (Xu et al., 1995).  
 
GH stimulation leads to phosphorylation of Elk-1 and transcriptional 
activation (Hodge et al., 1998). Overexpression of dominant-negative Ras or the 
ERK-specific phosphatase, mitogen-activated protein kinase phosphatase-1, or 
addition of the MEK inhibitor PD098059, blocked GH-stimulated activation of 
Ras/MEK/ERK pathway and abrogated GH-induced activation of Jun N-terminal 
kinase and phosphorylation of Elk-1 in 3T3-F442A cells (Hodge et al., 1998). GH 
also activates MAPK in a less direct manner, via tyrosine phosphorylation of the 
epidermal growth factor receptor, stimulating its association with Grb2, and 
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 resulting in activation of the MAPK signaling pathway in liver tissue (Yamauchi et 
al., 1998).  
 
PI3- kinase pathway.  GH induces tyrosine phosphorylation of insulin 
receptor substrate (IRS)-1/IRS-2 in liver (Yamauchi et al., 1998). IRS-1, -2, and -
3 are phosphorylated by JAK2 providing docking sites for p85 PI3-kinase and 
activating PI3-kinase leading to downstream biological effects (Yamauchi et al., 
1998). Wortmannin, a specific PI3-kinase inhibitor completely, blocked the anti-
lipolytic effect of GH in 3T3 L1 adipocytes (Yamauchi et al., 1998).   
 
STAT pathway.  GH activates JAK2 tyrosine kinase and members of the 
STAT family of transcription factors, including STATs 1, 3, and 5 (Smit et al., 
1997). At least two STAT5 proteins (STAT5A and STAT5B) exist in mouse and 
human (Smit et al., 1997). GH activates both STAT5A and STAT5B in several 
cell types (Smit et al., 1997).  GH-dependent tyrosyl phosphorylation of both 
STAT5A and STAT5B requires the same specific regions of the GHR and 
activation of JAK2 kinase (Smit et al., 1997). GH plays an important role in 
specific gene transcription through transient activation of STAT proteins (Rico-
Bautista et al., 2004). GH activates STAT5 by a rapid but transient mechanism 
that involves tyrosine phosphorylation and nuclear translocation (Fernandez et 
al., 1998). GH-induced STAT5 DNA-binding activity was detected after 2 min, 
reached a maximum at 10 min, decreased rapidly up to 1 hr of GH treatment, 
and the remaining activity declined slowly thereafter (Fernandez et al., 1998).  
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 Termination of GH signaling at the GHR/ JAK complex occurs through 
GH-induced ubiquitination/internalization of the GHR and also by the action of 
SOCS (suppressor of cytokine signaling) (Rico-Bautista et al., 2004). Greenhalgh 
and Alexander (2004) reported that SOCS are a family of proteins that are 
produced in response to signals from cytokines and growth factors and which act 
to attenuate cytokine signal transduction. Members of the SOCS family (SOCS-1 
to SOCS-7 and CIS) share a central SH2 domain and a C-terminal SOCS box 
and form a classical negative feedback loop that inhibit JAK/STAT signalling 
cascade (Larsen and Ropke, 2002). Recent studies indicated that SOCS bind to 
phosphotyrosines on the target protein through their SH2 domain, leading to 
inhibition of signal transduction by N-terminal inactivation of JAK resulting in 
blocking of access of STAT to the receptor sites (Larsen and Ropke, 2002). In 
addition, SOCS through their SOCS box-targeting bound proteins to proteasomal 
degradation (Larsen and Ropke, 2002).The expression of CIS, SOCS1, SOCS2 
and SOCS3 proteins is induced in cells stimulated with GH and their over-
expression in cell lines blocks aspects of GH signalling (Greenhalgh and 
Alexander, 2004). On the other hand, mice lacking SOCS2 display gigantism 
accompanied by evidence of lack of regulation of GH signaling (Greenhalgh et 
al., 2005). 
 
GH signaling is also affected by the integrity of cellular cytoskeleton. The 
GHR/JAK2/STAT5 signaling pathway is negatively regulated by the integrity of 
the actin cytoskeleton network, which facilitates GHR ubiquitination and 
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 degradation (Rico-Bautista et al., 2004). Rico-Bautista et al. (2004) investigated 
the effects of actin cytoskeleton disruption on the kinetics of GH-activated 
GHR/JAK2/STAT5 signaling pathway. They found that disruption of the actin-
based cytoskeleton with cytochalasin D (CytoD) prolonged both JAK2/STAT5 
tyrosine phosphorylation and STAT5 DNA binding activity. In addition, they 
demonstrated that although CytoD treatment did not affect the synthesis of 
SOCS proteins (SOCS-1, -2, and -3), the inhibitory actions of SOCS1, 2, and -3 
on GH-induced STAT5 reporter activity were partially blocked by disruption of the 
cytoskeleton. They also reported that the disassembly of actin filaments by 
CytoD was accompanied by accumulation of ubiquitinated forms of GHR, but it 
did not affect GHR internalization. 
  
Although GH-induced JAK2/STAT5 activation was independent of protein 
synthesis, a rapid decrease in STAT5 DNA-binding activity within 1 hour is 
dependent on protein synthesis (Fernandez et al., 1998).  JAK2 tyrosine 
phosphorylation and STAT5 DNA-binding activity were prolonged for at least 4 
hours in the presence of cycloheximide, a protein synthesis inhibitor, indicating 
that maintenance of desensitization requires ongoing protein synthesis 
(Fernandez et al., 1998). Termination of GH-induced STAT5b signaling involves 
down-regulation of JAK2 signaling to STAT5b by phosphotyrosine phosphatase 
(Gebert et al., 1999). 
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 Cellular stress may modulate transcription through the JAK/STAT 
pathway. Flores-Morales et al. (2001) reported that endoplasmic reticulum stress 
prevents the inactivation of STAT5 DNA binding activity by modulating the rate of 
JAK2/STAT5 dephosphorylation. They found that endoplasmic reticulum 
stressors dithiothreitol, calcimycin (A23187) and 1,2-bis(o-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid (acetoxymethyl) ester (BAPTA-AM) prolong GH-induced 
phosphorylation of JAK2 and STAT5.  
 
STAT5 pathway versus MAPK and PI3-kinase pathways in mediating 
GH action.   GH induces tyrosine phosphorylation of IRS-1/IRS-2 in liver 
(Yamauchi et al., 1998). IRS-1 expression augments the Ras/Raf/ MEK1 
/MAPK and PI3K pathways more than the tyrosine phosphorylation of STAT5 
(Liang et al., 2000). The level of GHR is rapidly reduced by short exposure to 
GH, which resulted in an equal desensitization of the JAK2/STAT5 pathway and 
time dependent recovery in the absence of GH (Ji et al., 2002). Unlike the 
JAK2/STAT5 pathway, the activating effect of GH on the MEK/ERK and PI 3-
kinase/Akt pathways did not recover following prolonged incubation in the 
absence of GH (Ji et al., 2002). This result indicates the presence of an 
additional post-receptor mechanism causing the prolonged refractoriness of the 
MEK/ERK and PI 3-kinase/Akt pathways in response to a second GH stimulation 
(Ji et al., 2002). The JAK2/STAT5 signaling pathway is required for GH/PRL-
induced pancreatic beta-cell proliferation; however, MAPK, PI3K, and PKC 
signaling pathways are not required (Friedrichsen et al., 2001).  
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 Protein synthesis, synaptic plasticity, and GH 
GH is well known for its ability to stimulate protein synthesis through both 
transcription and translation. GH/ IGF-1/insulin/ and p38 MAPK signaling 
pathways have important roles in the regulation of protein synthesis. Inhibition of 
the activity of these pathways plays an important role in the reduced rate of 
protein synthesis in aged rodents (Hsieh and Papaconstantinou, 2004). GHD has 
well known detrimental effects on cognition and memory in humans. Memory 
formation in mammals requires protein synthesis (Flexner et al., 1963; Davis and 
Squire, 1984). Studies in hippocampal slice preparations have distinguished two 
phases of LTP, an early phase (E-LTP) lasting for 2 hr and a late phase (L-LTP) 
which is greater in amplitude and longer in duration (> 3 hr) based on the 
differential sensitivities to mRNA and protein synthesis inhibitors (Nguyen et al., 
1994). Distinct temporal phases of memory and synaptic plasticity have been 
delineated in rodent hippocampus with long lasting forms distinguished by their 
dependence on macromolecular synthesis (Kelleher et al., 2004b). The 
regulation of protein synthesis underlying long-lasting synaptic plasticity might 
occur at the transcriptional or translational level (Kelleher et al., 2004b).  
 
The effect of protein synthesis inhibition on long lasting synaptic plasticity 
is a specific consequence of translational blockade and not due to non-specific 
effects or toxicity (Kelleher et al., 2004b). Several observations support this 
claim. First, the action of protein synthesis inhibitors is specific to long lasting 
forms of synaptic plasticity with no effect on the transient forms. Second, protein 
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 synthesis inhibitors typically interfere with the maintenance, not the initial 
induction of long lasting synaptic plasticity. Third, both L-LTP and L-LTD are 
blocked by protein synthesis inhibitors (Kelleher et al., 2004b). Fourth, calcium 
influx induced by depolarization or metabotropic GluR activation is not affected 
by the widely used protein synthesis inhibitor, anisomycin (Linden, 1996).  
Finally, several agonists such as BDNF and NT4, forskolin and memberane-
permeable cAMP analog Sp-cAMP, and dopamine receptor type D1/D5 agonists 
can induce the long lasting protein-dependent forms of LTP (Kang and Schuman, 
1995). The L-LTP induced by all those agents differs from L-LTP induced by 
repeated tetanization in that it develops gradually, requiring 1-2 hr to reach a 
maximum level and is abolished completely by pretreatment with protein 
synthesis inhibitors (Kelleher et al., 2004a).  
 
In order to answer the following questions, what signaling pathway(s) are 
responsible for short-term effects of GH on hippocampal synaptic function, and is 
synthesis of new proteins required for these effects?  I hypothesized that GHR 
signaling in hippocampus would use signaling pathways previously described in 
other tissues.  This hypothesis was tested by examining the effects of 
pharmacological inhibition of specific components of the hypothesized 
hippocampal GHR signaling pathway. The following set of experiments was 
conducted to assess the possible contributions of JAK2, STAT5, MAPK, and PI3-
kinase pathways, and protein synthesis to the GH-induced enhancement of 
excitatory synaptic transmission. 
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 Materials and methods 
 
 The methods used for hippocampal slice preparation, field potential 
recording and data analysis were as discussed in the previous section.  
  
To examine the effect of in vitro GH treatment on the expression of GH 
receptors and STAT5a/b, hippocampal slices were prepared and allowed to 
recover for 1 hr before use in experiments. For each experiment, slices obtained 
from the same animal were placed into 2 separate interface holding chambers. 
The slices in one chamber were exposed to ACSF alone to serve as a control, 
and in the other chamber slices were exposed to ACSF + 2 nM GH.  For 
detection of GHR mRNA, hippocampal slices were treated with GH (2 nM) or 
ACSF alone for 3 hr, then collected, rapidly frozen on dry ice, and stored at  
-80 °C until used for RNA isolation. For detection of total and phosphorylated 
STAT5a/b, hippocampal slices were treated with GH (2 nM) or ACSF alone for 
15-30 min, then were collected and rapidly frozen on dry ice, and stored at -80 °C 
until used for protein analysis. 
 
Western Blotting 
 Hippocampal slices were homogenized in protein lysis buffer [1% Nonidet 
P-40 (NP-40), 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 
0.15 M NaCl, 0.01 M sodium phosphate, pH 7.2, 2 mM ethylenediamine 
tetraacetic acid (EDTA), and 1% protease inhibitor cocktail]. Then, burst 
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 sonication was done (< 10 sec), and samples were centrifuged at 14,000 × g for 
20 min. at 4 °C. The supernatant solution was obtained and total protein 
estimated using the Bradford method (Bradford, 1976). Equal amounts of total  
protein from GH treated slices and control slices (200 µg) were separated on 8% 
polyacrylamide gels.  The separated proteins were transferred to nitrocellulose 
membranes (Micron Separations, Inc., Westboro, MA).  The membranes were 
blocked (1 hr at room temperature) in 5% nonfat dry milk in T-T-S (0.5% Tween-
20, 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.2 mM EDTA).  The membranes 
were then incubated with primary antibody diluted in 5% non-fat dry milk in T-T-S 
either at room temperature for 1 hr or overnight at 4 °C.  Next, membranes were 
then washed and incubated with horseradish peroxidase (HRP)-conjugated 
secondary antibodies, diluted 1:10,000 in 5% non-fat dry milk in T-T-S (1 hr at 
room temperature or 4 °C overnight).  Blots were washed again and proteins 
were detected on X-ray film (Fuji Medical System USA, Inc., Stamford, CT) using 
the ECL system (Amersham-Pharmacia), following the manufacturer’s 
instructions. To correct for possible loading differences, blots were probed with 
an antibody to neuron-specific enolase (NSE). The following primary antibodies 
were used:  anti-NSE (AB951, Chemicon International, 1:6000 to 1:8000), anti-
total STAT5 (Clone 89, Catalog Number # 610192, BD Bioscience, 1:250), anti-
phospho-STAT5 A/B (Y694/Y699) (mouse monoclonal IgG, clone 8-5-2; catalog 
# 05-495, Upstate Biotechnology, 1:250).  
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 RT-PCR 
 Total RNA from hippocampal slices was prepared using TRI Reagent 
(Sigma). cDNA was synthesized from 2.5 µg total RNA using 100µM random 
hexamer as primers. The mixture was heated to 65 °C for 5 min, and quickly 
chilled on ice. I added 4 µl of 5X First Strand Buffer (Invitrogen, Carlsbad, Ca), 
0.02 M DTT, and 40 U of Ribonuclease Inhibitor (Invitrogen), the reaction was 
placed in a PTC-100 thermal cycler and incubated at 25 °C for 10 min and then 
at 37 °C for 2 min. 200 U of M-MLVRT (Invitrogen) was added, and the mixture 
was incubated at 37 °C for 50 min and then at 70 °C for 15 min.  For the PCR 
reactions the following primers were used: GHR right 5´ (acttctgcggctgagcaaac) 
3´ and GHR left 5´ (ccttggagcaaaggatgacg) 3´.  The protocol for amplification 
was 95 °C for 1 min, 60 °C for 30 s and 72 °C for 1 min, for 35 cycles.  Using the 
cDNA prepared by RT-PCR, the following reaction was prepared: 50 µl total 
reaction volume; 33.5 µl of H2O, 0.5 µl of the right primer and 0.5 µl of the left 
primer, 0.5 µl of taq polymerase, 6 µl of 25 µM MgCL2, 1 µl of 10 µM dNTPs, 5 µl 
of 10X PCR buffer, and 2 µl of either samples or controls.  
 
Reagents 
 Reagents used in this study were rhGH (Bachem); 1,4-diamino-2,3-
dicyano-1,4-bis(2-aminophenylthio)-butadiene (U-0126);  tyrphostin AG 490 (LC 
Labs); wortmanin (WORT) (Sigma); cycloheximide (3-[2-(3,5-Dimethyle-2-
oxocyclohexyl)-2-hydrxyethyl]glutarimide) (Sigma). The last three reagents were 
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 dissolved in Dimethyle sulfoxide (DMSO). Salts and other compounds were from 
Sigma or Fisher.  
 
Data analysis  
 Field potentials were collected and analyzed using WinWCP program 
(John Dempster, University of Strathclyde). Densitometric analysis was 
conducted using ImageJ (Wayne Rasband, NIMH). Additional analysis was 
completed using Excel (Microsoft) and Origin (OriginLab). All statistics are 
presented as mean ± one standard error of the mean. Statistical significance was 
assessed using paired and unpaired t-test, as appropriate, with p<0.05 
considered significant. 
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 Results 
 
GH treatment of in vitro hippocampal brain slices increased the expression 
of GHR message 
To determine the effect of GH treatment on the expression pattern of GH 
receptors, I used RT-PCR of hippocampal brain slices treated with GH (2 nM) for 
3 hours GH treatment significantly increased (p< 0.002) the expression of GHR 
mRNA compared to control treated with ACSF alone (Figure 10). 
 
GH treatment of in vitro hippocampal brain slices did not alter total or 
phospho-STAT5A/B proteins 
 To examine the effect of GH treatment on the expression pattern of total 
and phospho-STAT5a,b, I used western blot analysis of hippocampal brain slices 
treated with GH (2 nM) for 15-30 min. GH treatment did not affect the protein 
levels of either total or phospho-STAT5a,b compared to control tissue treated 
with ACSF alone (Figure 11). 
 
GH-induced potentiation of fEPSPs was blocked by inhibitors of PI3 kinase, 
MAPK kinase, and JAK2 tyrosine kinase  
To investigate the role JAK2, PI3-kinase and MAPK in mediating the 
effects of GH on hippocampal synaptic transmission, I pretreated (30 min), 
hippocampal brain slices with tyrphostin AG 490 (10 µM) to block JAK2 protein 
tyrosine kinase, wortmannin (50 nM) to block the PI3-kinase signaling pathway, 
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 and U0126 (20 µM) to block the MAPK pathway. GH (1 nM) was then applied. 
Each of these three inhibitors significantly reduced the effect of GH on excitatory 
synaptic transmission in CA1 region of rat hippocampus. These results indicate 
that activation of JAK2, PI3-kinase and MAPK signaling pathways are all 
important for the induction of GH effect on hippocampal synapses (Figure 12). 
 
PI3-kinase and MAPK inhibitors had no effect on the maintenance of GH 
enhanced excitatory synaptic transmission in the hippocampus 
I conducted an additional experiment to determine if PI3-kinase and 
MAPK signaling pathways are important for the maintained effects of GH on 
hippocampal synaptic transmission. Hippocampal slices were treated with GH (1 
nM) for 30 min, to allow the initial enhancement by GH of synaptic transmission, 
then WORT (50 nM) or U-0126 (20 µM) were added along with GH for another 
30 min. Neither WORT nor U-0126 had any effect on the maintenance of GH 
enhancement of hippocampal synaptic transmission (Figure 13), suggesting that 
while PI3-kinase and MAPK are required for the initiation of GH-induced 
enhancement, neither is required for the maintained expression of GH-dependent 
synaptic enhancement.  
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 Protein synthesis is required for the induction of GH enhancement of  
synaptic transmission   
To investigate the role of protein synthesis in the induction of GH-
dependent synaptic enhancement, I pretreated hippocampal brain slices with 60 
µM cycloheximide for 30 min before GH (1 nM) treatment. Cycloheximide 
application was maintained during GH application for 1 hour Pretreatment with 60 
µM cycloheximide for 30 min completely blocked the GH effect on excitatory 
synaptic transmission of rat hippocampus. This result indicates that synthesis of 
new proteins is required for the induction of GH-dependent synaptic 
enhancement (Figure 14).  
 
Protein synthesis is not important for maintained expression of GH 
enhancement of synaptic transmission  
To determine the possible role of continued protein synthesis in the 
maintained expression of GH-dependent synaptic enhancement, I applied 
cycloheximide (60 µM) beginning 30 min after the start of GH (1 nM) treatment.  
Cycloheximide applied 30 min after initial treatment with GH had no effect on the 
maintained expression of GH enhancement of excitatory synaptic (Figure 15). 
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Figure 10.  GH treatment of in vitro hippocampal brain slices increased the 
n of GHR mRNA. 
A. Total RNA was prepared from hippocampal brain slices treated with GH (2 
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Figure 11.  GH treatment of in vitro hippocampal brain slices did not affect 
rotein levels of either total or phospho-STAT5a/b.  
Total protein was prepared from hippocampal brain slices treated with GH (2 
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 Figure 12.  GH-induced potentiation of the fEPSP was blocked by inhibition 
f PI3 kinase, MAPK kinase and JAK2 tyrosine kinase.  
A.  Slices were pretreated for 30 min with 50 nM WORT (up-triangle, n=8), 20 µM 
U0126 (circle, n=7), or 10 µM Tyrphostin AG490 (down-triangle, n=8) before the 
application of GH (1 nM). The application of these inhibitors completely blocked 
the normal enhancing effect of GH on excitatory synaptic transmission. In the 
sample fEPSPs shown in the insets at the top, baseline responses are indicated 
by thin lines and responses after GH application by thick lines.  
B.  Summary of effects of GH in slices pretreated with WORT, U-0126, and, 
Tyrphostin AG-490. There was no change in fEPSP following GH application in 
slices pretreated with WORT or U-0126 or Tyrphostin AG490 compared to 
baseline (p>.05). The increase in fEPSP slope following treatment with GH alone 
was significantly greater than slices pretreated with WORT, U-0126 and 
Tyrphostin AG 490 (p<0.05). *p<.05 vs GH, **p<.01 vs GH.  
o
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Figure 13. 
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 Figure 13.  PI3-kinase and MAPK kinase inhibitors had no effect on the 
maintained expression of GH enhancement of fEPSPs.   
A. WORT (50 nM) or U-0126 (20 µM) was applied 30 min after the initial 
application of GH (1 nM). Neither of these two inhibitors affected GH-dependent 
enhancement of excitatory synaptic transmission when inhibitor treatment 
followed initial GH application by 30 min. The insets at top illustrate the effects of  
GH alone or GH with WORT or with U-0126 applied 30 min after beginning GH 
treatment.  
B. Neither WORT nor U0126 inhibited maintenance of GH-induced enhancement 
of EPSPs. There was no significant difference between GH application alone or 
GH followed 30 min later with WORT or U0126 (p>0.1). The increases in EPSP 
slope following treatment with GH alone or GH followed by WORT or U0126 
were all significant when compared with pre-GH baseline (**p<0.01, ***p<.001).  
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 Figure 14.  Protein synthesis was required for the induction of GH 
enhancement of synaptic transmission.   
A. Pretreatment of hippocampal brain slices with 60 µM cycloheximide for 30 min 
before GH treatment (1 nM) completely blocked the normal GH enhancement of 
excitatory synaptic transmission. The insets at top show example recordings from 
individual slices (N= 6).  
B.  Summary comparison of the effects of GH alone, GH in slices pretreated with 
cycloheximide, and cycloheximide alone. There was no significant difference 
between GH application in slices pretreated with cycloheximide and control 
treated with ACSF or cycloheximide alone (p>0.1).  GH alone caused a 
significantly greater increase in EPSP slope than GH+cycloheximide (p< 0.004).  
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 Figure 15.  Protein synthesis was not required for maintained enhancement 
of EPSPs by GH.  
A.  The application of cycloheximide (60 µM) beginning 30 min after the start of 
GH treatment (1 nM) had no effect on GH-dependent EPSP enhancement. Slices 
were treated with GH alone (squares), or with cycloheximide beginning 30 min 
after initial application of GH (up-triangles). Control slices were treated with 
cycloheximide alone (circles). The insets at the top show fEPSPs from individual 
slices, (n = 7). 
B.  Summary comparison of the effects of GH, GH + cycloheximide, 
cycloheximide alone, and ACSF alone. There was no significant difference 
between GH alone and GH followed by cycloheximide (p>0.1).  The increases in 
EPSP slope following treatment with either GH or GH followed by cycloheximide 
were significantly greater compared to both ACSF (p<0.005) and cycloheximide 
(p<0.007) controls.  
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 Discussion 
 
In vitro GH treatment increased the expression of GH receptor message in 
hippocampus 
One of the factors that contributes to differential tissue responsiveness to
GH is tissue-specific autoregulation of GHRs and GHBPs. I used RT-PCR to
determine the effect of GH treatment on the expression of GHRs in hippocampal 
brain slices trea
 
 
ted with GH for 3 hours GH treatment increased the expression 
re 10).  This 
 
 also supported by the finding of Vikman et al. (1991) that 
HR mRNA levels  increased within 1 hr of a single injection of human GH (100 
g/rat), with maximal levels being reached  3-12 hr after the injection. In the 
ikman et al. (1991) study, the increase in GHR mRNA levels was dose 
ependent, and also was observed  after prolonged treatment (1 or 5 mg/kg/day 
r 6 days) with bovine GH. Furthermore, there was a rapid GH-dependent 
pregulation of GHR mRNA in adipose tissue (Vikman et al., 1991). Also, Le 
reves et al. (2002) reported an increase in the expression of GHR gene 
anscripts in young adult rats following GH treatment by s.c. injection for 10 
ays. 
of GHR mRNA compared to control treatment with ACSF alone (Figu
result is consistent with the previous findings of Hull and Harvey (1998), who
reported a 25-50% increase in GHR and GHBP mRNA in all brain regions of 
hypophysectomized rats following a single bolus GH injection.  
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lso found that JAK2 activation by GH triggered various pathways including 
K-2 tyrosine
th
excitatory synaptic transmission 
GH intera
ated tyrosine kinase, JAK2, and triggering signaling cascades involving  
STAT, Ras/Raf/MEK1/MAPK, and IRS-1/PI3-kinase pathways (Liang et al., 
2000). To investigate the role of JAK2, PI3-kinase and MAPK in mediating the 
effects of GH on hippocampal synaptic transmission, I pretreated hippocampal 
brain slices with tyrphostin AG 490 to block JAK2 protein tyrosine kinase, 
wortmannin to block the PI3-kinase signaling pathway, and U-0126 to block th
MAPK pathway. Pretreatment of slices for 1 hr with these inhibitors completel
blocked the normal enhancing effect of GH on excitatory synapt
(F
ng pathways are required for the induction of GH effects on hippocampal 
synapses.  
 
My results are consistent with the earlier work of Argetsinger et al.
and Sotiropoulos et al. (1994), who reported that activation of GHR stimulates 
JAK2 kinase and facilitates the association of GHR with JAK2 into a comple
with subsequent phosphorylation of both proteins. Many intracellular proteins 
subsequently phosphorylated in a cascade, including MAPK.  Kim et al. (1
also reported the requirement for GHR and JAK2 activation in GH signaling. 
They a
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 the Ras/MAPK, STAT, and IRS/PI3-kinase systems. Yamauchi et al. (1998) also 
reported that the PI3-kinase signaling pathway is important in mediating GH 
effect on 3T3 L1 adipocytes. They reported that wortmannin, a specific PI3-
kinase
 and 
 
 
ole for PI3-kinase or MAPK in the maintenance of GH-dependent 
PSP enhancement. My findings are consistent with the observation of Opazo et 
al. (20
y et 
 inhibitor, completely blocked the anti-lipolytic effect of GH on 3T3 L1 
adipocytes. Yamauchi et al. (1998) reported that GH induced tyrosine 
phosphorylation of IRS-1/IRS-2 in liver, with JAK2-phosphorylated IRS-1, -2,
-3 providing docking sites for p85 PI3-kinase and activating PI3-kinase for 
downstream biological effects. 
 
To determine if the PI3-kinase and MAPK signaling pathways are required
for the maintained expression of GH effects I treated hippocampal slices with 
WORT or U0126 beginning 30 min after initiation of GH treatment. Neither 
WORT nor U0126 had any inhibitory effect on already established GH 
enhancement of hippocampal synaptic transmission (Figure 13), suggesting that
there is no r
E
03) that PI-3 kinase is specifically involved in the induction of tetanus-
induced LTP, but is not required for maintenance of LTP.  
 
How might PI-3 kinase lead to enhanced synaptic transmission? Opazo et 
al. (2003) argued that PI3-kinase leads to downstream activation of the ERK 
pathway in tetanus-induced LTP. Other possibilities were suggested by Impe
al. (1998) and Davis et al. (2000), who reported that ERK activation contributed 
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 to LTP induction by facilitating transcriptional events, mRNA synthesis and 
protein synthesis. The effective blockade of L-LTP requires treatment with a 
translational inhibitor around the time of L-LTP induction, whereas treatment
L-LTP induction produces no effect (Otani et al., 1989; Frey and Morris, 1997
Alltogether, there is considerable evidence that both protein synthesis a
kinase activation are important for the induction but not the maintenance of LTP.  
 
Based on the roles of pro
 after 
). 
nd PI3-
tein synthesis and PI3-kinase, it seems possible 
at MAPK and ERK activation are also important for the induction of LTP but not 
for the
0).  
locked by 
of 
lices blocks 
ubsequent synaptic potentiation by tetanus. 
 
th
 maintenance of LTP. Both PI3-kinase and MAPK signaling pathways are 
important for LTP induced by repeated tetanization; MEK inhibitors strongly 
reduce the induction of LTP by TPS (Winder et al., 1999; Watabe et al., 200
Furthermore, LTP induced by short trains of TPS is almost completely b
the PI3-kinase inhibitors LY294002 and wortmannin (Opazo et al., 2003). The 
marked similarity in pathways required for GH enhancement of excitatory 
synaptic transmission and for tetanization induced L-LTP suggests that  
competition within a common set of  pathways may be the underlying cause 
my finding that GH pretreatment of rat hippocampal brain s
s
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 GH treatment of in vitro hippocampal brain slices does not affect total 
phospho-STAT5A/B protein levels. 
GH activates JAK2 tyrosine kinase and members of the STAT family of 
transcription factors, including STATs 1, 3, and 5 (Smit et al., 1997). GH plays a
important role in specific gene transcription through transient phosphorylational 
activation of STAT proteins (Rico-Bautista et al., 2004). GH-induced STAT5 
or 
n 
NA-binding activity was detected after 2 min, reached a maximum at 10 min,   
decrea
  
es 
 
Although GH has well known stimulating effects on three major signaling 
athways, there is considerable variability in the level of activation of these 
ifferent pathways among different tissues, and a corresponding variability in the 
importance of these three pathways in mediating specific effects of GH.  For 
D
sed rapidly with up to 1 hr of GH treatment, and declined slowly with even 
longer GH treatment (Fernandez et al., 1998). At least two STAT5 proteins 
(STAT5A and STAT5B) exist in mouse and human (Smit et al., 1997). GH 
activates both STAT5A and STAT5B in several cell types (Smit et al., 1997).
GH-dependent tyrosyl phosphorylation of both STAT5A and STAT5B requires 
the same specific regions of GHR and activation of JAK2 kinase (Smit et al., 
1997). To determine the effect of GH treatment on the expression of total and 
phospho-STAT5a,b, I used western blot analysis of hippocampal brain slic
treated with GH (2 nM) for 15-30 min. GH treatment did not affect protein
expression of total or phospho-STAT5a/b compared to ACSF alone control 
(Figure 11). 
 
p
d
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 example, Yamauchi et al. (1998) found that GH induced tyrosine phosphorylatio
of IRS-1/IRS-2 in liver, and the IRS-1 a
n 
ugmentation of Ras/Raf/MEK1/MAPK and 
PI3K p
e 
 hr 
d 
TAT5b via dephosphorylation by phospho-tyrosine phosphatase. 
ecause JAK2/STAT5 signaling is enhanced by protein synthesis inhibitors, 
wherea  
 
athways was greater than the tyrosine phosphorylation of STAT5 (Liang et 
al., 2000). Also, Ji et al. (2002) reported that unlike the JAK2/STAT5 pathway, 
the effect of GH on activation of the MEK/ERK and PI3-kinase/Akt pathways did 
not recover following prolonged incubation in the absence of GH. Finally, 
Friedrichsen et al. (2001) found that JAK2/STAT5 signaling pathway was 
required for GH/PRL-induced pancreatic beta-cell proliferation; however, MAPK, 
PI3K, and PKC signaling pathways were not required. 
   
I also found that GH action on excitatory synaptic transmission was 
blocked by pretreatment with cycloheximide, a protein synthesis inhibitor (Figur
16). In contrast, Fernandez et al. (1998) observed that JAK2 tyrosine 
phosphorylation and STAT5 DNA-binding activity were prolonged for at least 4
in the presence of cycloheximide. These discrepant observations can be 
explained by Gebert et al. (1999), who found that termination of GH-induce
STAT5b signaling is a complex process involving down-regulation of JAK2 
signaling to S
B
s GH enhancement of excitatory synaptic transmission was prevented by
protein synthesis inhibition, it seems even more unlikely that JAK2/STAT5 is
required for GH effects on hippocampal excitatory synaptic transmission. 
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 Protein synthesis is necessary for the induction but not the maintenance of 
GH enhancement of synaptic transmission  
 Protein synthesis in mammals is required for memory formation (Flexner 
et al., 1963; Davis and Squire, 1984). Studies in hippocampal slice preparations
have distinguished two phases of LTP, an early phase (E-LTP) lasting for 2 hr 
and a late phase (L-LTP) greater in amplitude and longer in duration more
hr, based on different sensitivities to mRNA and protein synthesis inhibitor
(Nguyen et al., 1994). In my experiments, GH enhanced excitatory synaptic 
transmission in CA1 area of rat hippocampus, and this 
 
 than 3 
s 
effect lasted for more than 
hour Because of the similar nature of the enhancement, and the similarity in 
signali es as 
tic 
uction 
y 
, 
onsequence of their translational blockade.  
3 s 
ng pathways, we may consider the GH effect on hippocampal synaps
a form of L-LTP. Kelleher et al. (2004a) reported the dependence on 
macromolecular synthesis for long lasting forms of memory and synap
plasticity in rodent hippocampus that might reflect regulation at the transcriptional 
or translational level. To investigate the role of protein synthesis in the ind
of GH-dependent L-LTP, I pretreated hippocampal brain slices with 60 µM 
cycloheximide for 30 min before GH treatment. This pretreatment completel
blocked the normal effect of GH on excitatory synaptic transmission (Figure 14)
emphasizing the importance of protein synthesis in the induction of GH-
dependent L-LTP. The validity of this interpretation of my data is supported by 
the finding of Kelleher et al. (2004a) who showed that the effects of protein 
synthesis inhibitors on long lasting synaptic plasticity are the specific 
c
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 Several agonists can induce long-lasting protein synthesis-dependent 
forms of LTP, including the neurotrophins BDNF and NT4, forskolin and the 
cally 
 treatment.  
 of GH 
 
al. 
 
dy 
memberane–permeable cAMP analog Sp-cAMP, and D1/D5 dopamine receptor 
agonists (Kang and Schuman, 1995). It is well known that L-LTP induced by 
repeated tetanization is dependent on protein synthesis. However, there are 
differences between L-LTP induced by pharmacological agents and L-LTP 
induced by repeated tetanization. Kelleher et al. (2004a) reported that chemi
induced L-LTP differs from tetanization induced L-LTP in that it develops 
gradually, requires 1-2 hr to reach a maximum level, and is nullified completely 
by pretreatment with protein synthesis inhibitors (Kelleher et al., 2004a). 
To test the role of protein synthesis in the maintenance of GH-dependent  
L-LTP, I applied cycloheximide beginning 30 min after initiation of GH
Cycloheximide applied 30 min after GH had no effect on the maintenance
enhanced excitatory synaptic transmission (Figure 15). Studies on L-LTP have 
indicated that effective inhibition requires treatment with a translational inhibitor 
around the time of L-LTP induction, whereas delayed treatment after L-LTP
induction has no effect (Otani et al., 1989; Frey and Morris, 1997). Kelleher et 
(2004a) reported that rates of protein synthesis increased rapidly following L-LTP
induction. They added that failure of translational inhibitors to affect alrea
established L-LTP argues against the simple requirement of ongoing protein 
synthesis to maintain steady-state protein level.  
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 Previous studies indicate that repeated tetanization induces rapid 
enhancement of protein synthesis, which is necessary for full L-LTP express
(Kelleher et al., 2004a). Also, increased rates of protein synthesis can be 
detected rapidly after L-LTP induction (Kelleher et al., 2004b). Taken together
both kinds of L-LTP, drug-induced and tetanization-induced, require protein 
synthesis for their induction, then we might expect competitive inhibition of 
tetanus-induced L-LTP by previous GH-induced L-LTP.  
ion 
, if 
 for 
he PI-3 kinase pathway and 
rotein synthesis. Solid lines indicate direct effects and dashed lines indicate 
indirect effects.   
 
 
 
Figure 16.  Diagrammatic illustration of the proposed signaling pathway
GH in the hippocampus.  GHR dimerization and activation of JAK2 leads to 
stimulation of the MAPK pathway, stimulation of t
p
 8585
 How m tic 
of the 
 
I3-
tic 
 of substrate proteins or 
 
interactions
et al. (2000) reported that IRS-1 expression augments both the 
as/Raf/MEK1/MAPK and the PI3K pathways. So there is a possibility that GH 
 
sal 
 
ight growth hormone contribute to enhanced excitatory synap
transmission in rat hippocampus? 
GH activates GHRs leading to receptor dimerization and activation 
non-receptor tyrosine kinase, JAK2. JAK2 activation by GH triggers the activation
of various pathways including Pl3-kinase and the Ras/MAPK systems. Both P
kinase and MAPK mediate GH-dependent enhancement of excitatory synap
transmission in rat hippocampus through phosphorylation
stimulation of protein translation. The GH activation of PI3-kinase and MAPK 
pathways begins with GH-induced JAK2 phosphorylation, since GH effects on 
EPSPs were blocked by the JAK2 inhibitor. In support of the requirement for 
JAK2, Kim et al. (1998) found that GHR and JAK2 activation are required for GH 
signaling, and Yamauchi et al. (1998) reported that activation of JAK2 by GH 
binding to its receptor mediates the biological actions of GH.  
Although JAK2, PI-3 kinase and MAPK are required, the specific 
 leading from JAK2 to PI-3 kinase and MAPK are not certain.  Liang 
R
activates JAK2, which in turn activates IRS-1, which then mediates GH-
dependent activation of both PI3-kinase and MAPK. To test this possibility, we
would need to be able to assay IRS activation by phosphorylation, and the cau
relationship of IRS phosphorylation with respect to both PI-3 kinase and MAPK
activation.  
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 The second possibility is that activated GHR-JAK2 in turn activates the 
H stimulates tyrosine phosphorylation of 
the ep
e 
t L-
is regulation could 
ccur at either the translational level or the transcriptional level, or both. 
Howev lation at 
, 
 the presence of 
n of 
for synaptic regulation.  
MAPK signaling pathway without a requirement for IRS or PI-3 kinase.  
Yamauchi et al. (1998) reported that G
idermal growth factor receptor and causes its association with Grb2, 
resulting in stimulation of the MAPK signaling pathway in liver. In addition, 
Vanderkuur et al. (1997) reported that GH promoted the rapid, transient 
association of SHC with the Grb2-SOS complex, which correlated with the time 
course of Ras, Raf, and MEK activation.  In the Vanderkurr et al. (1997) study, 
Ras, Raf, and MEK returned to near basal activity after 15 to 30 min despite th
continuous presence of GH. Further investigation will be required to determine 
the specific pathway linking GHR-JAK2 to MAPK in the hippocampus.  
 
Synthesis of new proteins is required for the induction of GH-dependen
LTP of excitatory synaptic transmission in rat hippocampus. Th
o
er, the rapid onset of GH effects favors the enhancement of trans
the ribosomal level. This hypothesis is supported by the finding of Bodian (1965)
Autilio et al. (1968), and Morgan and Austin (1968) who reported
ribosomal assemblies in neuronal dendrites and the ability of isolated synaptic 
fractions to support de novo protein synthesis. In addition, the observatio
Steward and Levy (1982) that dendritic polyribosomes preferentially localized 
near postsynaptic sites, suggests that local protein synthesis may be important 
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 An important question, as yet unanswered, is how GH promotes local 
protein synthesis. As a potential mechanism, I propose that GH activation of PI3-
kinase t 
nd Le 
nts 
n into 
olve this 
ay 
nhances protein synthesis at the transcription level. In favor of this possibility is 
the fin
ic 
 leads to activation of another mediator that promotes protein synthesis a
the level of translation. This proposal is supported by Chou et al (1998) a
Good et al. (1998), who reported that PI3-kinase stimulates PDK-1, activating 
PKCζ.  Further support comes from the finding that inhibition of PKCζ preve
LTP in the hippocampal CA1 region (Ling et al., 2002).  Further investigatio
GH-dependent L-LTP, for example, with PKCζ inhibitors, may help to res
issue. 
 
Although there is evidence for GH stimulation of protein synthesis via 
activation of PI-3 kinase, the MAPK pathway could also link GHR activation to 
protein synthesis.  I propose that GH through stimulation of MAPK pathw
e
ding of Hodge et al. (1998) that GH promotes phosphorylation of Elk-1 
which in turn causes transcriptional activation. In addition, these same authors 
found that overexpression of dominant-negative Ras and the ERK-specif
phosphatase (mitogen-activated protein kinase phosphatase-1), and the 
application of MEK inhibitor PD098059, blocked GH-stimulated activation of 
Ras/MEK/ERK pathway and abrogated the GH-induced stimulation of the 
transcription factors Jun N-terminal kinase and Elk-1 in 3T3-F442A cells.  
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NMDA Receptor-Mediated Effects of Growth Hormone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section III 
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 Introduction 
 
Functional roles of NMDAR subunits composition  
The NMDAR is an ionotropic glutamate receptor defined by its selective 
activation by the agonist N-methyl-D-aspartate. The NMDAR plays crucial roles 
in synaptic plasticity and development, and also in excitotoxic injury (Grosshans 
and Browning, 2001, Mallon et al., 2004).   NMDARs are multimeric proteins 
containing two obligatory NR1 subunits, usually paired with two NR2A or NR2B 
subunits (Cull-Candy et al., 2001).  
 
While the NR1 subunit is obligatory for channel function, the NR2 
composition plays an important functional modulatory role, affecting channel 
kinetics and pharmacology (Yoshimura et al., 2003).  Differences in NR2 subunit 
composition underlie age-dependent changes in NMDAR dependent excitatory 
postsynaptic current (EPSC) kinetics and pharmacology (Flint et al., 1997). The 
proportion of the cells displaying fast NMDAR EPSCs and NR2A increases 
during postnatal development (Flint et al., 1997). In visual cortex, NR2 subunit 
composition changes with visual experience, in addition to age, affecting 
neocortical plasticity through differential subunit regulation at inhibitory and 
excitatory connections (Yoshimura et al., 2003).  
 
LTP induction depends on both NMDA receptor-mediated Ca2+ influx and 
subunit-specific signaling, with the intracellular C-terminal domain of the NR2 
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 subunits directing signaling pathways with an age-dependent preference (Kohr et 
l., 2003).   LTP induction at mature CA3-to-CA1 connections results primarily 
om NR2A-type signaling and NR2A-type receptors. Mutant mice lacking the 
tracellular C-terminal domain (NR2A∆C/∆C) were deficient in calcium signaling 
quired for LTP induction (Kohr et al., 2003). In young (<14 day old), but not 
ature (>42 day old) mice, NR2B-containing receptors participated in LTP 
duction.  Consistent with the different roles of NR2A and NR2B in immature 
nd adult hippocampus, CA3-to-CA1 LTP in NR2A∆C/∆C was more strongly 
duced in adult than young mice, but could be restored to wild-type levels by 
repeated tetanic stimulation (Kohr et al., 2003).  
 
NMDARs have been implicated in both LTP and LTD for many years 
(Dudek and Bear, 1992; Bliss and Collingridge, 1993).  The ability of NMDARs to 
participate in opposite forms of synaptic plasticity may be related to the pattern of 
synaptic activation required to induce LTP or LTD. These different patterns of 
synaptic stimulation resulted in corresponding differences in calcium signaling.  
Long trains of low frequency synaptic stimulation produce modest but prolonged 
elevation of intracellular calcium ion leading to LTD via the activation of 
phosphatases (Lisman, 1989). On the other hand, high frequency trains of 
synaptic stimulation produce a greater rise in intracellular calcium leading to LTP 
via stimulation of protein kinases (Lisman, 1989).  An additional factor allowing 
NMDARs to participate in multiple, opposing forms of plasticity is the NR2 
subunit composition of the receptor, since activation of NMDARs can produce 
a
fr
in
re
m
in
a
re
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 either increases or decreases in synaptic efficiency depending on subunit 
composition (Bliss and Schoepfer, 2004). 
specific antagonists ( Nishiyama et al., 2000; 
ummings et al., 1996). On the other hand, APV (0.5 µM) prevented HFS-
induce lective 
A 
 
distinct roles in long-term 
ynaptic plasticity (Erreger et al., 2005). Recordings from outside-out patches 
that co
 
Ifenprodil (3 µM) and Ro25-6981 (0.5 µM), selective antagonists of the 
NR2B subunit, completely blocked LTD induced by low-frequency stimulation 
(Liu et al., 2004; Williams, 2001). Although LTP is more sensitive to partial block 
of NMDARs by low concentration of APV, neither Ifenprodil nor Ro25-6981 
affected the induction of LTP by high frequency stimuli (HFS), indicating the 
selective blockade of LTD by NR2B 
C
d LTP without affecting LFS-induced LTD (Liu et al., 2004). The se
effect of low dose APV on LTP was explained by a requirement for NR1-NR2
NMDARs (Liu et al., 2004), since the NR2A containing NMDARs are more 
sensitive to APV blockade than NR2B containing receptors (Buller et al., 1994). 
An NR2A specific antagonist NVP-AAMO77 (0.4 µM) prevented both normal LTP
induced by a single episode of HFS and saturated LTP induced by multiple 
episodes of HFS, but had little effect on LFS-induced LTD (Liu et al., 2004).   
 
The relative expression levels of NR2A and NR2B is regulated 
developmentally and may allow NMDARs to play 
s
ntain a single active channel show that NR2A-containing receptors have a 
higher probability of opening and a higher peak open probability than NR2B-
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 containing receptors in response to a brief synaptic-like pulse of glutamate 
(Erreger et al., 2005). At high frequency tetanic stimulation (100 Hz; >100ms), 
typically used to induce LTP, the charge transfer mediated by NR1/NR2A 
considerably exceeds that of NR1/NR2B (Erreger et al., 2005).  In contrast, 
under low frequencies simulation typically used to induce LTD (1 Hz), NR1/NR
makes a larger contribution to total charge transfer and therefore calcium in
than NR1/NR2A (Erreger et al., 2005). 
 
Additional regulatory control over NMDAR function is exerted by subunit
specific phosphorylation of NMDARs (Lau and Hu
2B 
flux 
 
ganir, 1995).  In particular, 
rosine phosphorylation of NR2 subunits is thought to be important for regulating 
NMDA nity 
, 
tion 
ty
 receptor function (Lau and Huganir, 1995).  Studies using immunoaffi
chromatography of detergent extracts of rat synaptic plasma membranes on anti-
phosphotyrosine antibody-agarose demonstrated that the NR2A and NR2B 
subunits, but not NR1 subunits, are tyrosine-phosphorylated (Lau and Huganir
1995). The selective tyrosine phosphorylation of NR2A and NR2B, but not NR1, 
was confirmed by immunoprecipitation of the NR1, NR2A, and NR2B subunits 
with subunit specific antibodies followed by immunoblotting with anti-
phosphotyrosine antibodies (Lau and Huganir, 1995).  Tyrosine phosphoryla
of glutamate receptors was specific to the NMDA receptor.  No tyrosine 
phosphorylation of the AMPA (GluR1-4) or kainate (GluR6/7, KA2) receptor 
subunits was detected (Lau and Huganir, 1995).  
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 Protein kinase C (PKC) potentiates NMDA receptor function via acti
of non-receptor tyrosine kinases leading to
vation 
 tyrosine phosphorylation of NR2A 
and/or NR2B (Grosshans and Browning, 2001). Tyrosine phosphorylation of both 
NR2A -
ns 
ar 
s 
 
 
 
 
ensity protein of 95 kDa (PSD-95) (Gardoni et al., 2001). The dynamic and 
recipro  important 
n of 
l 
and NR2B is increased following treatment of rat hippocampal CA1 mini
slices with 500 nM phorbol 12-myristate 13-acetate (PMA) for 15 min (Grossha
and Browning, 2001).  Phosphorylation of serine 890 on the NR1 subunit is 
increased with PMA treatment for 5 min with phosphorylation returning to ne
basal levels by 10 min while tyrosine phosphorylation of NR2A and NR2B wa
sustained for up to 15 min (Grosshans and Browning, 2001). Phosphorylation of 
NR2A, NR2B and NR1 was blocked by pretreatment with the selective PKC
inhibitor chelerythrine, with the tyrosine kinase inhibitor Lavendustin A or with the
Src family tyrosine kinase inhibitor PP2 (Grosshans and Browning, 2001).  
 
One additional mechanism for regulating NMDAR function is protein-
protein interactions among the distinct protein components of the postsynaptic 
density (PSD). The three major components of the PSD are the NMDAR, the
Ca2+/ calmodulin-dependent protein kinase II (α-CaMKII), and the postsynaptic
d
cal interactions of the NMDAR, α-CaMKII, and PSD-95 have an
role in hippocampal synaptic plasticity (Gardoni et al., 2001).  The associatio
both native and recombinant α-CaMKII and PSD-95 depends on the C-termina
NR2A (S1389-V1464) sequence (Gardoni et al., 2001). Activation of NMDARs, 
by either pharmacological means or by LTP-inducing synaptic stimulation, 
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 modulated the association of α-CaMKII and PSD-95 with the NR2A C-tail 
(Gardoni et al., 2001).  
 
Correlation of GH, GluRs, MEK/ERK and Pl 3-kinase/Akt pathways         
GH modulates many functions of the central nervous system, improving 
memory, alertness and motivation (Fargo et al., 2002). It is well documented tha
GH secretion declines slowly with age r
  
t 
eaching 25% of the adolescent level in 
ery old age (Corpas et al., 1993). Magnusson et al. (2002) demonstrated a 
signific
s 
e 
anges in  
ease of 
nths 
ession of these receptor 
ubtypes.  
v
ant drop in the protein expression of the major subunits of the NMDA 
receptor occur during the aging process. They indicated that subunit alteration
may explain some of the changes that are seen in NMDA receptor functions 
during aging.  
 
Sonntag et al. (2000) studied the effects of age and chronic insulin-lik
growth factor-1 (IGF-1) administration on NMDA receptor density and subtype 
expression in frontal cortex, CA1, CA2/3 and the dentate gyrus of the 
hippocampus of young (10 months), middle-aged (21 months) and old (30 
months) male Fisher 344xBrown Norway (F1) rats. No age-related ch
125I-MK-801 binding or NMDAR1 protein expression were observed in 
hippocampus or frontal cortex. However, they reported a significant decr
NR2A and NR2B protein expression in hippocampus between 21 and 30 mo
of age, and administration of IGF-1 increased expr
s
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 In addition, GH might affect the expression of NMDA receptors in a more 
direct way.  GH treatment by subcutaneous injection for 10 days caused up 
regulation of GHRs and NR2B receptor subunits, and led to a significant increase 
in the NR2B/NR2A ratio in the hippocampus of young adult rats (Le Greves et a
2002). Aging normally leads to decreased NR1 expression in rats. This age-
dependent effect was antagonized by GH treatment (Le Greves et al., 2002)
Le Greves et al. (2002) found a significant positive correlation between the leve
of GHR mRNA and NR2B gene transcripts indicating a GHR-mediated effect on
the synaptic function of the NMDAR complex.  
 
Declining GH during aging may have other consequences for the synaptic 
mechanisms of memory. GH induces the activation of Raf/MEK1/MAPK and
l., 
.   
l 
 
 PI3-
inase pathways in several different tissues (Winston and Hunter, 1995; 
Vande l., 
al., 
zo 
 
k
rkuur et al., 1997; Hodge et al., 1998; Yamauchi et al., 1998; Kim et a
1998; Liang et al., 2000; Ji et al., 2002). NMDA receptor-dependent LTP is 
inhibited by drugs that inhibit PI3-kinase and MAPK/ERK activation (Opazo et 
2003). Several findings indicated that the Ras signaling pathway has an 
important role in NMDA receptor-dependent forms of synaptic plasticity (Opa
et al., 2003). Hippocampal LTP is altered in mice with mutations affecting H-Ras 
(Manabe et al., 2000), Ras GTPase-activating protein NF1 (neurofibromin) 
(Costa et al., 2002) or SynGAP (a synaptic Ras-GTPase activating protein) 
(Komiyama et al., 2002). PI3-kinase inhibitors also inhibt NMDAR mediated ERK
activation (Opazo et al., 2003).  
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   In addition to regulating MAPK/ERK activation, PI3-kinase may con
to LTP by controlling the
tribute 
 trafficking of AMPA-type glutamate receptors.  PI3-
inase is involved in the trafficking and insertion of GluR1 subunits of AMPA-type 
chang
ly 
itter 
nists to pharmacologically isolate NMDAR and AMPAR 
omponents of synaptic transmission, tested GH for effect on these isolated, 
compo  
have 
nt 
k
glutamate receptors (Passafaro et al., 2001), including activity-dependent 
es in AMPA receptor trafficking-insertion that are implicated in LTP 
(Malinow and Malenka, 2002). Membrane insertion of GluR1-containing AMPA 
receptors induced by NMDA receptor activation in cultured neurons is complete
blocked by the PI3-kinase inhibitor wortmannin (Passafaro et al., 2001).  
 
 To answer the question, whether GH effects on hippocampal synaptic 
function are mediated by NMDARs or AMPARs? I used specific neurotransm
receptor antago
c
nents and compared the isolated NMDAR-mediated fEPSPs (fEPSPNs)
and isolated AMPAR-mediated fEPSPs (fEPSPAs) to the dual component 
fEPSPs.  To address the question, does short-term treatment with GH 
similar consequences on NMDAR expression as long-term, chronic treatme
with GH? I used western blotting to measure NMDA-NR1, NR2A, and NR2B 
expression levels in GH treated and control rat hippocampal slices.  
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 Materials and Methodes 
 
Electrophysiology 
 The methods used for hippocampal slice preparation, field potential 
recording and data analysis were as discussed in section I. To isolate AMPA
dependent responses I treated slices with the NMDAR antagonist 5-amino-
R-
specific competitive antagonist of 
MPAR, and bicuculline methiodide (BMI 10 µM), a specific competitive 
antago
phosphovaleric acid (D-AP5 50 µM) for 30 min before GH application. To isolate 
NMDAR-dependent responses, hippocampal slices were pretreated with 6-7-
dinitroquinoxalline-2-3-dione (DNQX 30 µM), a 
A
nist of the GABAA
d has 
 receptor, for 30 min before application of GH. This 
pharmacological method of isolating AMPAR- and NMDAR-mediated synaptic 
responses was originally described by Davies and Collingridge (1989), an
been widely used since then.  
 
Western Blotting 
To examine the effect of GH on the expression of NMDAR subunit
hippocampal slices were prepared as described in earlier sections and allowed t
recover for 1 hour After recovery, slices obtained from the same animal were 
placed into 2 separate interface chambers. The slices in one chamber were 
exposed to ACSF alone to serve as a control, and the slices in the other cha
were exposed to ACSF + GH (2 nM).  After 3 hours of treatment, both groups of 
s, 
o 
mber 
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 slices were rapidly frozen on dry ice and stored at -80 °C until used for protein 
isolation. 
 Hippocampal slices were homogenized in protein lysis buffer [1% Nonidet 
P-40 (NP-40), 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SD
0.15 M NaCl, 0.01 M sodium phosphate, pH 7.2, 2 mM ethylenediamine 
tetraacetic acid (EDTA), and 1% protease inhibitor cocktail]. Then, burst 
sonication was done (< 10 sec), and samples were centrifuged at 14,000 × g for 
20 min. at 4 °C. The supernatant solution was obtained and total protein 
S), 
estimated using the Bradford method (Bradford, 1976). Equal amounts of total  
protein % 
 were 
room 
 and 
, 
 4 
on X-ray 
film (Fuji Medical System USA, Inc., Stamford, CT) using the ECL system 
mersham-Pharmacia), following the manufacturer’s instructions.  To correct for 
ossible loading differences, blots were probed with an antibody to neuron-
pecific enolase (NSE). The following primary antibodies were used:  anti-NSE 
 from GH treated slices and control slices (200 µg) were separated on 8
polyacrylamide gels. The separated proteins were transferred to nitrocellulose 
membranes (Micron Separations, Inc., Westboro, MA).  The membranes
blocked (1 hour at room temperature) in 5% nonfat dry milk in T-T-S (0.5% 
Tween-20, 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.2 mM EDTA), and then 
incubated with primary antibody diluted in 5%  non-fat dry milk in T-T-S (at 
temperature for 1 hour, or overnight at 4 °C).  Membranes were then washed
incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies
diluted 1:5000 in 5% non-fat dry milk in T-T-S (1 hour at room temperature or
°C overnight).  Blots were washed again and proteins were detected 
(A
p
s
 999
 (AB951, Chemicon Internat ti-NMDA-R1 (60021A, 
harMingen International, 1:1000), anti-NMDA-R2A (AB1555P, Chemicon, 1:500 
DA-R2B (N38120, Transduction Laboratories, 1:2000 to 
ional, 1:6000 to 1:8000), an
P
to 1:2000), anti-NM
1:4000).  
 
Reagents 
 Reagents used in this study were recombinant human GH (rhGH) 
(Bachem), ranging from 1-2 nM (22-44 ng/ml); bicuculline methiodide (BMI 10
µM), 6-7-dinitroquinoxalline-2-3-dione (DNQX 30 µM) (Tocris) and 5-amino-
phosphovaleric acid (D-AP5 50 µM). BMI and DNQX were dissolved in D
AP5 was dissolved in 100 mM NaOH. 
 
 
 
 
MSO. 
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 Results 
 
NQX 
 shown 
 
mined 
, 
 
s in 
GH-induced potentiation of NMDAR-mediated fEPSPs (fEPSPNs) 
To determine if GH can enhance NMDAR-mediated excitatory synaptic 
transmission, I isolated fEPSPNs by pretreating hippocampal slices with D
(30 µM) to block AMPARs and BMI (10 µM) to block GABAA receptors (as
in figure 17 and 19). GH enhanced pharmacologically isolated NMDAR-mediated
excitatory synaptic transmission in CA1. To ensure that the response exa
in this experiment was actually due to NMDAR activation, I applied AP5 (50 µM)
to block NMDARs, at the end of the two hours period of GH application. AP5 
blocked the previous GH enhancement, verifying that GH had acted through 
NMDARs to enhance excitatory synaptic transmission.  
 
GH-induced potentiation of AMPAR-mediated fEPSPs (fEPSPAs) 
To determine if GH enhances AMPAR-mediated excitatory synaptic 
transmission in the CA1 region, I pretreated hippocampal slices with AP5 (50 µM) 
beginning 30 min before GH application to isolate fEPSPAs (Figure18 and 19). 
GH caused significant enhancement of fEPSPAs. GH enhancement of fEPSPAs
was significantly greater than the dual component fEPSPs (when GH was 
applied without AP5). This result suggests that GH can act through AMPAR
addition to NMDARs.   
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 GH treatment decreased the expression of NR2B protein  
NMDARs have an important role in synaptic plasticity (Grosshans and 
Browning, 2001; Mallon et al., 2004). Previous studies showed that NMDAR 
activation can produce either increases or decreases in synaptic efficiency 
epending on the subunit composition of NMDAR (Bliss and Schoepfer, 2004). In 
estigate the effect of GH treatment on subunit composition of 
 (2 
e 
sed 
d
order to inv
NMDARs, hippocampal brain slices were perfused in ACSF containing GH
nM) for 3 hours Control slices were perfused with ACSF alone for the same tim
period.  Western blotting of hippocampal slice homogenates revealed decrea
protein expression of NR2B, but no change in NR2A or NR1  (Figure 20).   
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igure 17.  GH enhanced isolated NMDAR-mediated  fEPSPs (fEPSPNs). 
ore GH 
application) with DNQX (30 µM) to block AMPA receptors and BMI (10 µM) to 
block G A 5, at 
response recorded during the pre-GH baseline period (thin solid line), the 
 was 
compared to baseline recording and compared to ACSF alone control 
re was no significant difference between application of 
H alone and GH+DNQX+ BMI, p>.05.  
 
F
GH (1 nM) enhanced fEPSP in slices pretreated (beginning 30 min bef
ABA receptors.   Addition of the NMDAR competitive antagonist, AP
the end of the two hours GH application period verified that the enhanced fEPSP 
was mediated by NMDA receptors (see the inset top left). The inset shows the 
response during 2nd hour of GH treatment (thick solid lines), and the response 
after addition of AP5 (dotted line). Significant enhancement of fEPSP slope
obtained in both GH alone (squares, n=10) and GH+DNQX (circles, n=5) 
(diamonds), p<.05. The
G
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Figure 18.   GH enhanced isolated AMPAR-mediated fEPSPs (fEPSPAs) 
GH (1 nM) enhanced fEPSP slope in slices pretreated with AP5 (50 µM, 
beginning 30 min before GH application) to block NMDARs. The inset shows 
fEPSPs during the 15 min baseline recording (thin lines), and fEPSPS during the 
2ndh of GH treatment (thick lines) either in the presence (n=6) or absence of AP5, 
(n=10). GH significantly enhanced fEPSP in the presence of AP5 (uptriangles) 
compared to its absence (squares, p<.05).  EPSPs slope was significantly 
enhanced in both the presence and absence of AP5 compared to baseline 
recording and compared to ACSF control (diamonds, p<.05). 
 
 104
 
 0
100
200
300
400
500
AC
SF GH
GH
+D
NQ
X+
BM
I
GH
+A
P5
fE
P
S
P
 s
lo
pe
 (%
 b
as
el
in
e)
1st hr
2nd hr
+
+
+
ns
*
 
Figure 19.  Summary comparison of effects of GH alone, GH+DNQX+BMI, 
GH+AP5 and control ACSF. GH enhanced both fEPSPNs and fEPSPAs. Non 
the dual component fEPSPs. Results represent the mean ± SE during the 
 
, 
+ = significant difference at p<0.02 compared to pre-GH baseline and ACSF 
 
 
significant change between the GH enhancement of fEPSPNs and dual 
component fEPSPs. GH enhancement of fEPSPAs was significantly higher than 
indicated time periods; * = significant difference at p<0.04 compared to GH
treatment alone, ns = nonsignificant compared to GH application alone at p>0.3
alone.  
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 Figure 20.  GH decreased NR2B, but not NR1 or NR2A protein  
A. Hippocampal slices were treated with 2 nM GH or ACSF alone for 3 hours.  
Western blotting of slice homogenates revealed decreased NR2B protein in GH 
treated tissue. NR2A and NR1 levels were unaffected by GH treatment. NSE was 
used as a loading control.  
B. Statistical analysis of GH effects on NMDAR subunit expression.  Blots were 
analyzed by densitometry, and normalized relative to control. GH caused a 
significant decrease in NR2B protein (**p<0.007, n = 12), but NR1 (p<0.2, n =12) 
and NR2A (p<0.2, n =12) were not altered by GH.   
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 Discussion 
 
GH affects the expression of NMDARs, which are required for normal 
emory function. In tetanization-induced LTP, NMDARs play an important role in 
the induction of synaptic potentiation, by allowing calcium influx into postsynaptic 
neurons during high frequency stimulation, and the block of NMDARs, for 
example, by AP5, inhibits LTP (Bliss and Collingridge, 1993).  It is well known 
that LTP is triggered by calcium influx into postsynaptic neurons in the CA1 area 
of the hippocampus. Although metabotropic GluRs and voltage-gated calcium 
channels contribute to postsynaptic calcium increase under some circumstances, 
NMDARs are the major route for calcium entry (Bliss and Collingridge, 1993). To  
isolate NMDAR mediated synaptic responses and examine effects of GH, slices 
were perfused with ACSF containing DNQX and BMI beginning 30 min before 
and continuing during GH treatment (Figure 17). I found that GH caused an 
enhancement of fEPSPNs that appeared essentially identical in amplitude and 
time course with the GH-enhancement of dual component fEPSPs. Thus, the 
enhancing effect of GH on fEPSPs in area CA1 is mediated in part by NMDARs. 
  
 
Previous studies indicated that over activation of NMDARs before or 
during tetanic train reduces the probability to generate LTP of the fEPSPAs 
(Coen et al., 1989; Huang et al., 1992; Izumi et al., 1992; Neuman et al., 1987), 
without preventing LTP of pharmacologically isolated fEPSPNs (Bashir et al., 
m
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 1991; Berretta et al., 1991; Gozlan et al., 1994; Xie et al., 1992). To determine if 
al inhibition of NMDARs by AP5 and treatment with 
 
 on NMDARs, and 
pplication of strong tetanic stimulation significantly potentiated the isolated 
PSPAs. However, strong tetanus in the absence 7Cl¯-kyn did not affect 
PSPAs. In the study of Aniksztejn and Ben-Ari (1995), the authors tested the 
ypothesis that the expression of LTP by AMPARs and NMDARs depends on the 
egree of NMDAR activation during the tetanus. They found that LTP of 
PSPAs has a lower threshold than that of fEPSPNs. They suggested that tetani 
at generate LTP of fEPSPNs have a low probability of inducing LTP of 
PSPAs. They concluded that AMPA and NMDA components are potentiated 
rough two different postsynaptic processes. Aniksztejn and Ben-Ari (1995) 
roposed a model representing the relative contribution of AMPARs & NMDARs 
 LTP as function of degree of NMDAR activation (Figure 21).  
 
GH enhancement of excitatory synaptic transmission in the CA1 region of 
hippocampus is also mediated by AMPARs, hippocampal slices were perfused 
with ACSF containing the NMDAR blocker AP5 to isolate fEPSPAs. My results 
indicate that pharmacologic
GH produced enhancement of isolated fEPSPAs that is significantly greater than
dual component fEPSPs (Figure 18 and 19). This result is supported by the 
finding of Aniksztejn and Ben-Ari (1995) that addition of 7-Chlorolynurenate 
(7Cl¯-kyn), an antagonist of the allosteric glycine site
a
fE
fE
h
d
fE
th
fE
th
p
to
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Figure 21.   Model representing the relative contribution of AMPARs and 
NMDARs to LTP as function of degree of NMDARs activation. The degree of 
n. 
At the beginning of tetanization AMPAR contribution to the postsynaptic 
response is high. However, with progressively greater NMDAR activation, the 
PA contribution to tetanization decreases gradually until it vanishes, resulting 
in the bell shaped response to tetanization (modified from Aniksztejn and Ben-
Ari, 19
 
In agreement with the results of Aniksztejn and Ben-Ari, 1995; Gozlan et 
contribution of AMPARs to LTP depends on the the degree of NMDAR activatio
AM
95).   
al., 1994; Huang et al., 1992; Izumi et al., 1992; Xie et al., 1992; Bashir et al., 
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 1991; Berretta et al., 1991; Coen et al., 1989; Neuman et al., 1987, I suggest that
GH produces strong activation of NMDARs that inhibits the AMPAR contrib
to GH-dependent L-LTP. However, keep in mind that the GH effect was of slow 
onset resulting in a gradual increase in the number of NMDARs activated. 
Therefore, it is wise not to rule out the possibility of an AMPAR contribution to 
fEPSP enhancement at least during the initial 30 min of GH treatment. It is 
important to understand how NMDARs could exert a negative regulatory effe
on the AMPAR’s response to GH. Iwakura et al. (2001) found that NMDA 
treatment of cultured hippocampal neurons reduced the total number of 
AMPARs on the neuronal surface, but not in the total membrane fraction. Th
also observed that NMDA-treatment caused down-regulation of AMPA-stim
channel activity and reduced immunoreactivity for GluR1. They concluded that 
NMDAR activation induced down-regulation of functional AMPARs. Further 
investigation is needed to clarify the mechanism by which GH-induced NM
activation limits the response of AMPARs. 
 
NMDAR antagonists block the induction of both LTP and LTD (Bliss and 
Collingridge, 1993; Dudec and Bear, 1992), and the NMDAR subunit compos
is considered a determining factor for LTP or LTD (Bliss and Schoepfer, 2004; 
Liu et al., 2004).  To investigate the role of NMDAR subunit com
 
ution 
ct 
bound 
ey 
ulated 
DAR 
ition 
position in 
ediating GH effects, hippocampal brain slices were perfused with ACSF 
ontaining GH (2 nM) for 3 hours Western blots of GH treated slices showed 
m
c
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 decreased protein expression of the NR2B subunit of NMDARs (Figure 20). 
HFS and s
ity in 
NR2B-subunit-containing receptors limit NMDAR function by inhibitory restraint 
over NR2A-subunit-containing receptors, via calcineurin activation (Mallon et al., 
2004).  
 
In my experiments, GH decreased the expression of NR2B subunits but 
not the NR2A subunits. According to the findings of Mallon et al. (2004), Liu et al. 
(2004), Bliss and Schoepfer (2004), Bliss and Collingridge (1993), and Dudec 
and Bear (1992), this decrease in the NR2B subunit should allow enhanced 
function of the NR2A-containing NMDARs.The relative loss of NR2B compared 
to NR2A after GH treatment might therefore contribute to the GH-induced 
enhancement of fEPSPs. 
NR2A and NR1 protein level were unaffected by GH treatment for 3 hours. 
  
Liu et al. (2004) reported the requirement of NMDARs that is lacking their 
NR2B subunits for LTP induction. The use of the NR2A specific antagonist NVP-
AAMO77 (0.4 µM) prevented both normal LTP induced by a single episode of 
aturated LTP induced by multiple episodes of HFS, but had little effect 
on LFS-induced LTD (Liu et al., 2004).  Mallon et al. (2004) reported that “LTP 
induction critically involves primarily receptors containing the NR2A subunit”. 
They added that “endogenous factors or drugs that modify this NR2B/NR2A 
interaction could have a major influence on synaptic transmission and plastic
the brain”. At both presynaptic and postsynaptic sites in the rat hippocampus, 
 112
  
 
 
 
Figure 22.  Diagrammatic illustration of t
 
he proposed mechanism of 
interaction between GH, PI3-kinase, MAPK, and NMDARs. GH activates 
GHR/JAK2, which activates PI3-kinase. PI3-kinase activates Fyn tyrosine kinase, 
which then activates NMDARs. NMDARs activate SynGAP, converting inactive 
 and 
My results indicate that GH-induced L-LTP was mediated at least in part 
by NMDARs. Also GH treatment for 3 hours decreased expression of the NR2B 
ras to active ras and activating MAPK pathway.  
 
Proposed mechanisms of interaction between GH, PI3-kinase, MAPK,
NMDARs 
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 subunit, supporting my earlier finding that GH enhanced fEPSPNs. An import
question here is: How does GH regulate NMDAR subunit expression and 
ant 
NMDAR function? In addition, my finding that PI3-kinase and MAPK were 
import  
5, 
et 
 that GH activation of the JAK2/PI3-kinase pathway enhances NMDAR 
ctivation probably by phosphorylation, and also contributes to down-regulation 
of NR2 t 
n 
f 
ant for the induction of GH effects on fEPSPs raises another question, how
GH-induced enhancement of NMDAR function is related to PI3-kinase and 
MAPK signaling pathways? 
 
Recent studies have shown that the regulatory subunit of PI3-kinase, P8
binds directly to NR2B subunits (Hisatsune et al., 1999). Also PI3-kinase 
stimulates a group of tyrosine kinases called Fyn tyrosine kinase (Hisatsune 
al., 1999). MEK and ERK are regulated by SynGAP, a Ras GTPase-activating 
protein that binds PSD-95 (Kim et al., 1998). More recent studies show that 
NMDARs join large multiprotein complexes that contain a number of proteins 
involved in Ras signaling (Husi et al., 2000). Taken together, These results 
suggest
a
B subunits allowing NR2A to become dominant mediating GH-dependen
L-LTP (Figure 22). In addition, GH might also activate the MAPK pathway 
through the association of NMDARs, PSD-95 and SynGAP. Further investigatio
is needed to know the exact molecular mechanisms that link GH stimulation o
PI3-kinase and MAPK to NMDARs. 
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CONCLUSION 
 115
  Previous studies have shown that GH affects many functions of the central
nervous system, with beneficial effects on memory, alertness and motivatio
Others indicated that a common set of cellular mechanisms link GH-induce
improvement of memory function to NMDARs and LTP. Yet the mechanisms by 
which GH improves memory function of the brain or how GH-induced 
improvement of memory func
 
n.  
d 
tion relates to NMDARs and LTP are not well 
stablished. The purpose of this study was three-fold.  First, to determine if the 
short t
ine 
r 
K2, 
d 
nsmission was mediated through NMDARs.  
Finally, GH treatment of hippocampal brain slices increased GHR message and 
decreased the abundance of NR2B protein.   
e
erm treatment with GH affects synaptic transmission in CA1 area of rat 
hippocampus. Second, if GH does affect synaptic transmission, to determ
which GH-signaling pathway or pathways are required, and to determine whethe
protein synthesis is required. Third, to determine the roles of AMPARs and 
NMDARs in mediating GH action.   
  
In summary, my results showed that GH caused a long-lasting 
enhancement of excitatory synaptic transmission in area CA1 of rat 
hippocampus.  This GH-induced L-LTP blocked further potentiation by tetanus. 
GH did not act through an increase in probability of glutamate release from 
presynaptic terminals. The GH-induced potentiation of fEPSPs required JA
PI3-kinase, and MAPK, and the synthesis of new protein, but only during 
induction of potentiation, and not during maintenance of potentiation. GH-induce
potentiation of excitatory synaptic tra
 116
 My results demonstrate that GH induced L-LTP is related to both 
MDARs channel activity and subunit composition, and there are common 
ignaling pathways underlying GH-induced L-LTP and tetanization-induced L-
TP. Thus, GH enhancement of synaptic transmission in the hippocampus might 
xplain the well known finding that GH treatment improves cognition and 
emory. My discovery that GH is a potent short-term modulator of excitatory 
ynaptic transmission in the hippocampus will facilitate a deeper understanding 
f neuroendocrine regulation of memory function. However, this discovery raises 
ew issues that were not apparent previously. Future studies will be needed in 
several areas. First, to verify the echanisms by which GH 
duces activation of GHR/JAK2, PI3-kinase and MAPK, and alters NMDAR 
xpression and protein synthesis. Second, to determine whether GH stimulates 
F-I release and to assess whether IGF-I participates in the short term effects of 
H in hippocampus. 
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